Anhang II REG_2009_790 | Lawbster

Index-Nr.

Internationale chemische Bezeichnung EG-Nummer CAS-Nummer Einstufung Kennzeichnung Spezifische Konzentrationsgrenzen, M-Faktoren Anmerkungen

Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung Kodierung der Gefahrenhinweise Piktogramm, Kodierung der Signalworte Kodierung der Gefahrenhinweise Kodierung der ergänzenden Gefahrenmerkmale

003-003-00-5 (2-methylpropyl)lithium; isobutyllithium 440-620-2 920-36-5 Water-react. 1 Pyr.

Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H260 H250 H314 H336 H400 H410 GHS02 GHS05 GHS07 GHS09 Dgr H260 H250 H314 H336 H410 EUH014

005-007-00-2 boric acid; [1] boric acid, crude natural, containing not more than 85 per cent of H 3BO3 calculated on the dry weight [2] 233-139-2 [1] 234-343-4 [2] 10043-35-3 [1] 11113-50-1 [2] Repr. 1B H360FD GHS08 Dgr H360FD Repr. 1B; H360FD: C ≥ 5,5 %

005-008-00-8 diboron trioxide; boric oxide 215-125-8 1303-86-2 Repr. 1B H360FD GHS08 Dgr H360FD Repr. 1B; H360FD: C ≥ 3,1 %

005-011-00-4 disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3] 215-540-4 [1] 235-541-3 [2] 237-560-2 [3] 1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] Repr. 1B H360FD GHS08 Dgr H360FD Repr. 1B; H360FD: C ≥ 4,5 %

005-011-01-1 disodium tetraborate decahydrate; borax decahydrate 215-540-4 1303-96-4 Repr. 1B H360FD GHS08 Dgr H360FD Repr. 1B; H360FD: C ≥ 8,5 %

005-011-02-9 disodium tetraborate pentahydrate; borax pentahydrate 215-540-4 12179-04-3 Repr. 1B H360FD GHS08 Dgr H360FD Repr. 1B; H360FD: C ≥ 6,5 %

005-013-00-5 diethylmethoxyborane 425-380-9 7397-46-8 Pyr.

Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 H250 H332 H312 H302 H373** H314 H317 H413 GHS02 GHS05 GHS08 GHS07 Dgr H250 H332 H312 H302 H373** H314 H317 H413

005-014-00-0 4-formylphenylboronic acid 438-670-5 87199-17-5 Skin Sens. 1 H317 GHS07 Wng H317

005-015-00-6 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 414-380-4 140681-55-6 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412

005-016-00-1 tetrabutylammonium butyl tris-(4- tert-butylphenyl)borate 431-370-5 — Aquatic Chronic 4 H413 — H413

005-017-00-7 sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 231-556-4 [2] 15120-21-5 [1] 7632-04-4 [2] Oxid.

Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 H272 H360Df H302 H335 H318 GHS03 GHS05 GHS08 GHS07 Dgr H272 H360Df H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-017-01-4 sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 231-556-4 [2] 15120-21-5 [1] 7632-04-4 [2] Oxid.

Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 H272 H360Df H331 H302 H335 H318 GHS03 GHS06 GHS05 GHS08 Dgr H272 H360Df H331 H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. 1B STOT SE 3 Eye Dam. 1 H360Df H335 H318 GHS05 GHS08 GHS07 Dgr H360Df H335 H318 Repr. 1B; H360 Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 H360Df H332 H335 H318 GHS05 GHS08 GHS07 Dgr H360Df H332 H335 H318 Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-019-00-8 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] Oxid.

Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 H272 H360Df H302 H335 H318 GHS03 GHS05 GHS08 GHS07 Dgr H272 H360Df H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-019-01-5 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] Oxid.

Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 H272 H360Df H331 H302 H335 H318 GHS03 GHS06 GHS05 GHS08 Dgr H272 H360Df H331 H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

006-091-00-3 propineb (ISO); polymeric zinc propylenebis(dithiocarbamate) — 9016-72-2 Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 H332 H373** H317 H400 GHS08 GHS07 GHS09 Wng H332 H373** H317 H400

006-092-00-9 tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate 425-420-5 98737-29-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

006-093-00-4 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) 427-180-7 — Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410

006-094-00-X O-isobutyl-N-ethoxy carbonylthiocarbamate 434-350-4 103122-66-3 Flam.

Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 H226 H350 H340 H302 H373** H317 H411 GHS02 GHS08 GHS07 GHS09 Dgr H226 H350 H340 H302 H373** H317 H411

006-095-00-5 fosetyl-aluminium (ISO); aluminium triethyl triphosphonate 254-320-2 39148-24-8 Eye Dam. 1 H318 GHS05 Dgr H318

006-096-00-0 chlorpropham (ISO); isopropyl 3-chlorocarbanilate 202-925-7 101-21-3 Carc. 2 STOT RE 2 * Aquatic Chronic 2 H351 H373** H411 GHS08 GHS09 Wng H351 H373** H411

006-097-00-6 1-phenyl-3-( p-toluenesulfonyl)urea 424-620-1 13909-63-2 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 H302 H373** H412 GHS08 GHS07 Wng H302 H373** H412

006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate 429-170-8 134575-17-0 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 H302 H373** H318 H317 GHS05 GHS08 GHS07 Dgrg H302 H373** H318 H317

006-099-00-7 N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate 432-520-2 232938-43-1 Aquatic Chronic 2 H411 GHS09 H411

006-101-00-6 reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] 423-070-8 — Aquatic Chronic 4 H413 — H413

006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate 432-750-3 — Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 H350 H340 H302 H373** H317 H411 GHS08 GHS07 GHS09 Dgr H350 H340 H302 H373** H317 H411

006-103-00-7 N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea 445-760-8 — Eye Dam. 1 Resp.

Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H334 H400 H410 GHS05 GHS08 GHS09 Dgr H318 H334 H410 M=100

007-028-00-2 hydroxylammonium nitrate 236-691-2 13465-08-2 Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H201 H351 H311 H302 H373** H319 H315 H317 H400 GHS01 GHS06 GHS08 GHS09 Dgr H201 H351 H311 H302 H373** H319 H315 H317 H400

007-029-00-8 diethyldimethylammonium hydroxide 419-400-5 95500-19-9 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314

012-004-00-X aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate 422-150-1 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

013-010-00-5 hydroxy aluminium bis(2,4,8,10-tetra- tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide) 430-650-4 151841-65-5 Aquatic Chronic 2 H411 GHS09 H411

014-033-00-3 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica 419-030-4 125804-20-8 Flam.

Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336

014-034-00-9 3-hexylheptamethyltrisiloxane 428-700-5 1873-90-1 Acute Tox. 4 * Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413

014-035-00-4 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane 425-050-4 10217-34-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

014-036-00-X (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane 405-020-7 105024-66-6 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360F*** H400 H410 GHS08 GHS09 Dgr H360F*** H410 M=1000

014-037-00-5 2-butanone- O,O',O''-(phenylsilylidyne)trioxime 433-360-6 34036-80-1 STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 H373** H317 H412 GHS08 GHS07 Wng H373** H317 H412

014-038-00-0 S-(3-(triethoxysilyl)propyl) octanethioate 436-690-9 220727-26-4 Skin Sens. 1 H317 GHS07 Wng H317

014-039-00-6 (2,3-dimethylbut-2-yl)-trimethoxysilane 439-360-2 142877-45-0 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412

014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane 445-890-5 201290-01-9 Acute Tox. 4 * Skin Sens. 1 H302 H317 GHS07 Wng H302 H317

014-042-00-2 reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) 423-010-0 — Eye Dam. 1 H318 GHS05 Dgr H318

014-043-00-8 reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) 432-200-2 — Aquatic Chronic 2 H411 GHS09 H411

014-044-00-3 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane 433-050-0 — Aquatic Chronic 2 H411 GHS09 H411

014-045-00-9 magnesium sodium fluoride silicate 442-650-1 — STOT RE 2 * H373** GHS08 Wng H373**

015-113-00-0 tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate 260-515-3 57018-04-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

015-182-00-7 tetraisopropyldichloromethylenebisphosphonate 430-630-5 10596-22-2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS06 Wng H302 H319 H317

015-183-00-2 (1-hydroxydodecylidene)diphosphonic acid 425-230-2 16610-63-2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410

015-188-00-X (1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate 425-220-8 5945-33-5 Aquatic Chronic 4 H413 — H413

015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 421-920-2 154862-43-8 Aquatic Chronic 4 H413 — H413

015-191-00-6 dodecyldiphenyl phosphate 431-760-5 27460-02-2 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412

015-192-00-1 tetrakis(2,6-dimethylphenyl)- m-phenylene biphosphate 432-770-2 139189-30-3 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

015-193-00-7 triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro- N-methyl-1-butanesulfonamide (1:1) 442-960-7 332350-93-3 Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H400 H410 GHS05 GHS06 GHS09 Dgr H301 H318 H410

015-194-00-2 tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate 444-440-5 220689-12-3 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

015-195-00-8 reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate 433-860-4 — Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H317 H412 GHS07 Wng H319 H317 H412

015-196-00-3 reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate 435-960-3 — Carc. 1B Muta. 1B Skin Sens. 1 H350 H340 H317 GHS08 GHS07 Dgr H350 H340 H317

015-197-00-9 bis(2,4,4-trimethylpentyl)dithiophosphonic acid 420-160-9 107667-02-7 Flam.

Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 H226 H331 H302 H314 H411 GHS02 GHS06 GHS05 GHS09 Dgr H226 H331 H302 H314 H411

015-198-00-4 (4-phenylbutyl)phosphinic acid 420-450-5 86552-32-1 Carc. 2 Eye Dam. 1 H351 H318 GHS05 GHS08 Dgr H351 H318

016-092-00-0 reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol 427-050-1 — Repr. 1A Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H315 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H361f H315 H317 H410

016-094-00-1 sulfur 231-722-6 7704-34-9 Skin Irrit. 2 H315 GHS07 Wng H315

016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 434-480-1 32047-53-3 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H302 H314 H317 H412 GHS05 GHS07 Dgr H302 H314 H317 H412

017-023-00-7 [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy- N,N-dimethyl-N-(C6-18)-alkyl] trichlorides 425-520-9 197179-61-6 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

022-004-00-1 potassium titanium oxide (K 2Ti6O13) 432-240-0 12056-51-8 Carc. 2 H351 GHS08 Dgr H351

022-005-00-7 [ N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium 419-840-8 169104-71-6 Flam.

Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 H228 H314 H317 H413 GHS02 GHS05 GHS07 Dgr H228 H314 H317 H413

024-021-00-X potassium tetrasodium bis[( N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) 425-830-4 — Eye Dam. 1 H318 GHS05 Dgr H318

026-003-00-7 iron(II) sulfate 231-753-5 7720-78-7 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315

026-003-01-4 iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate 231-753-5 7782-63-0 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 Skin Irrit. 2; H315: C ≥ 25 %

026-004-00-2 potassium ferrite 430-010-4 12160-44-0 Skin Corr. 1B Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317

027-006-00-6 cobalt acetate 200-755-8 71-48-7 Carc. 1B Muta. 2 Repr. 1B Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F*** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F*** H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=10 1

027-007-00-1 zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex 425-240-7 — Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411

027-008-00-7 complex of cobalt(III)-bis( N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3) 427-390-9 — Skin Sens. 1 H317 GHS07 Wng H317

027-009-00-2 cobalt nitrate 233-402-1 10141-05-6 Carc. 1B Muta. 2 Repr. 1B Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F*** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F*** H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=10 1

027-010-00-8 cobalt carbonate 208-169-4 513-79-1 Carc. 1B Muta. 2 Repr. 1B Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F*** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F*** H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=10 1

028-002-01-4 nickel powder; [particle diameter < 1 mm] 231-111-4 7440-02-0 Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 H351 H372** H317 H412 GHS08 GHS07 Dgr H351 H372** H317 H412

028-011-00-6 nickel dichloride 231-743-0 7718-54-9 Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 STOT RE. 1; H373: C ≥ 1 % STOT RE. 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M=1

028-012-00-1 nickel dinitrate; [1] nitric acid, nickel salt [2] 236-068-5 [1] 238-076-4 [2] 13138-45-9 [1] 14216-75-2 [2] Ox.

Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H272 H350i H341 H360D*** H372** H332 H302 H318 H315 H317 H400 H410 GHS03 GHS05 GHS08 GHS07 GHS09 Dgr H272 H350i H341 H360D*** H372** H332 H302 H318 H315 H317 H410 STOT RE. 1; H373: C ≥ 1 % STOT RE. 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M=1

028-013-00-7 nickel matte 273-749-6 69012-50-6 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-014-00-2 slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate 295-859-3 92129-57-2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1

028-015-00-8 slimes and sludges, copper electrolyte refining, decopperised 305-433-1 94551-87-8 Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D*** H372** H334 H317 H410 H

028-016-00-3 nickel diperchlorate; perchloric acid, nickel(II) salt 237-124-1 13637-71-3 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H314 H334 H317 H400 H410 GHS05 GHS08 GHS09 Dgr H350i H341 H360D*** H372** H314 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 H

028-017-00-9 nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] 237-563-9 [1] 239-793-2 [2] 13842-46-1 [1] 15699-18-0 [2] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D*** H372** H332 H302 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 H

028-018-00-4 nickel bis(sulfamidate); nickel sulfamate 237-396-1 13770-89-3 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D*** H372** H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 H

028-019-00-X nickel bis(tetrafluoroborate) 238-753-4 14708-14-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-021-00-0 nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-022-00-6 nickel di(acetate); [1] nickel acetate [2] 206-761-7 [1] 239-086-1 [2] 373-02-4 [1] 14998-37-9 [2] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp.

028-024-00-7 nickel dibenzoate 209-046-8 553-71-9 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-025-00-2 nickel bis(4-cyclohexylbutyrate) 223-463-2 3906-55-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-026-00-8 nickel(II) stearate; nickel(II) octadecanoate 218-744-1 2223-95-2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-027-00-3 nickel dilactate — 16039-61-5 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-028-00-9 nickel(II) octanoate 225-656-7 4995-91-9 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp.

028-029-00-4 nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] 233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-030-00-X nickel hexafluorosilicate 247-430-7 26043-11-8 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-031-00-5 nickel selenate 239-125-2 15060-62-5 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-032-00-0 nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 H

028-033-00-6 diammonium nickel hexacyanoferrate — 74195-78-1 Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 H

028-034-00-1 nickel dicyanide 209-160-8 557-19-7 Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 EUH032 H

028-035-00-7 nickel chromate 238-766-5 14721-18-7 Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 H

028-036-00-2 nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-037-00-8 dinickel hexacyanoferrate 238-946-3 14874-78-3 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-038-00-3 trinickel bis(arsenate); nickel(II) arsenate 236-771-7 13477-70-8 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H372** H317 H410 H

028-039-00-9 nickel oxalate; [1] oxalic acid, nickel salt [2] 208-933-7 [1] 243-867-2 [2] 547-67-1 [1] 20543-06-0 [2] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-040-00-4 nickel telluride 235-260-6 12142-88-0 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-041-00-X trinickel tetrasulfide — 12137-12-1 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-042-00-5 trinickel bis(arsenite) — 74646-29-0 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-043-00-0 cobalt nickel gray periclase; C.I.

Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] 269-051-6 [1] 261-346-8 [2] - [3] 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372** H317 GHS08 GHS07 Dgr H350i H372** H317 H

028-044-00-6 nickel tin trioxide; nickel stannate 234-824-9 12035-38-0 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372** H317 GHS08 GHS07 Dgr H350i H372** H317 H

028-045-00-1 nickel triuranium decaoxide 239-876-6 15780-33-3 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372** H317 GHS08 GHS07 Dgr H350i H372** H317 H

028-046-00-7 nickel dithiocyanate 237-205-1 13689-92-4 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D*** H372** H334 H317 H410 EUH032 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 H

028-047-00-2 nickel dichromate 239-646-5 15586-38-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-048-00-8 nickel(II) selenite 233-263-7 10101-96-9 Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 H

028-049-00-3 nickel selenide 215-216-2 1314-05-2 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-050-00-9 silicic acid, lead nickel salt — 68130-19-8 Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H360Df H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H360Df H372** H317 H410 H

028-051-00-4 nickel diarsenide; [1] nickel arsenide [2] 235-103-1 [1] 248-169-1 [2] 12068-61-0 [1] 27016-75-7 [2] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-052-00-X nickel barium titanium primrose priderite; C.I.

Pigment Yellow 157; C.I. 77900 271-853-6 68610-24-2 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372** H317 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H

028-053-00-5 nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-054-00-0 nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(d-gluconato- O 1,O 2)nickel; [18] nickel 3,5-bis( tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato- O)(isononanoato-O)nickel; [21] (isononanoato- O)(isooctanoato-O)nickel; [22] (isooctanoato- O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato- O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato- O)(neodecanoato-O)nickel; [25] (isodecanoato- O)(isooctanoato-O)nickel; [26] (isodecanoato- O)(isononanoato-O)nickel; [27] (isononanoato- O)(neodecanoato-O)nickel; [28] fatty acids, C 6-19-branched, nickel salts; [29] fatty acids, C 8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp.

028-055-00-6 nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] Carc. 1A STOT RE 1 Resp.

Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372** H334 H317 H410 H

028-056-00-1 nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372** H317 H410 H

028-057-00-7 dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372** H317 GHS08 GHS07 Dgr H350i H372** H317 H

028-058-00-2 cobalt lithium nickel oxide 442-750-5 — Carc. 1A Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H330 H372** H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350i H330 H372** H317 H410

029-014-00-5 reaction mass of: 2,2'-[[ cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex; 2,2'-[[ trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex 419-610-7 171866-24-3 STOT RE 2 * Aquatic Chronic 2 H373** H411 GHS08 GHS09 Wng H373** H411

030-009-00-5 zinc-bis(4-( n-octyloxycarbonylamino)salicylate) dihydrate 417-130-2 — Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411

030-010-00-0 2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt 430-740-3 — Aquatic Chronic 2 H411 GHS09 H411

030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 Aquatic Chronic 3 H412 — H412

030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 — Aquatic Chronic 2 H411 GHS09 H411

040-003-00-4 reaction product of 3,5-di- tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5 430-610-6 226996-19-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

042-005-00-0 reaction mass of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex 434-240-6 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

046-001-00-X tetraammine palladium(II) hydrogen carbonate 425-270-0 134620-00-1 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373** H318 H317 H410

047-002-00-8 polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt 416-850-4 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

050-021-00-4 dichlorodioctyl stannane 222-583-2 3542-36-7 Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 H331 H372** H412 GHS06 GHS08 Dgr H331 H372** H412

050-022-00-X dibutyltin dichloride; (DBTC) 211-670-0 683-18-1 Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H341 H360FD H330 H301 H312 H372** H314 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H341 H360FD H330 H301 H312 H372** H314 H410 Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10

050-023-00-5 reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane 422-920-5 — STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H373** H400 H410 GHS08 GHS09 Wng H373** H410 M=10

050-024-00-0 reaction mass of: tri- p-tolyltin hydroxide; hexa- p-tolyl-distannoxane 432-230-6 — STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H372** H302 H315 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H372** H302 H315 H318 H317 H410

064-001-00-8 gadolinium(III)sulfite trihydrate 456-900-2 51285-81-5 Aquatic Chronic 2 H411 GHS09 H411

078-010-00-X tetraammine platinum(II) hydrogen carbonate 426-730-3 123439-82-7 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

078-011-00-5 hydroxydisulfito platinum(II) acid 423-310-1 61420-92-6 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Resp.

Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H373 H314 H334 H317 H412 GHS05 GHS08 GHS07 Dgr H302 H373 H314 H334 H317 H412

078-012-00-0 platinum(IV) nitrate/nitric acid solution 432-400-1 — Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410

082-012-00-6 barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped 431-780-4 199876-46-5 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 H302 H373** H411 GHS08 GHS07 GHS09 Wng H302 H373** H411

601-070-00-0 reaction mass of: branched icosane; branched docosane; branched tetracosane 417-050-8 151006-58-5 Acute Tox. 4 * Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413

601-072-00-1 reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane 430-690-2 52783-21-8 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410

601-075-00-8 4,4'-bis( N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane 418-770-5 151882-81-4 Carc. 2 H351 GHS08 Wng H351

601-076-00-3 ethynyl cyclopropane 425-430-1 6746-94-7 Flam.

Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H225 H315 H318 H412 GHS02 GHS05 Dgr H225 H315 H318 H412

601-077-00-9 reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane 426-510-7 196965-91-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

601-078-00-4 reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane 427-040-5 — Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410

601-079-00-X reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene 429-620-3 — Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413

601-080-00-5 reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-( sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-( sec-butylphenyl-1-phenylethane, mixed isomers 431-100-6 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

601-081-00-0 cyclohexadeca-1,9-diene 431-730-1 4277-06-9 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413

601-082-00-6 reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane 434-420-4 — Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410

601-083-00-1 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene 435-000-3 22094-83-3 Asp.

Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 H304 H315 H413 GHS08 GHS07 Dgr H304 H315 H413

601-084-00-7 reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) 435-180-3 — Asp.

Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H304 H315 H400 H410 GHS08 GHS07 GHS09 Dgr H304 H315 H410

602-095-00-X alkanes, C 14-17, chloro; chlorinated paraffins, C 14-17 287-477-0 85535-85-9 Lact.

Aquatic Acute 1 Aquatic Chronic 1 H362 H400 H410 GHS09 Wng H362 H410 EUH066

602-098-00-6 2-(3-bromophenoxy)tetrahydro-2 H-pyran 429-030-6 57999-49-2 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

602-099-00-1 3-(4-fluorophenyl)-2-methylpropionylchloride 426-370-7 — Skin Corr. 1A Acute Tox. 4 * Aquatic Chronic 3 H314 H302 H412 GHS05 GHS07 Dgr H314 H302 H412 EUH014 EUH029

602-100-00-5 reaction mass of: ( R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; ( S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane 420-640-8 — Aquatic Chronic 3 H412 — H412

602-101-00-0 2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate 427-020-6 141772-37-4 STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373** H317 H400 H410 GHS08 GHS07 GHS09 Wng H373** H317 H410

602-102-00-6 1,1,1,3,3-pentafluorobutane 430-250-1 406-58-6 Flam.

Liq. 2 H225 GHS02 Dgr H225

602-103-00-1 1-(chlorophenylmethyl)-2-methylbenzene 431-450-1 41870-52-4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410

602-104-00-7 1,1,2,2,3,3,4-heptafluorocyclopentane 430-710-1 15290-77-4 Aquatic Chronic 3 H412 — H412

602-105-00-2 sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate 422-100-7 102061-82-5 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

602-106-00-8 2-bromo-4,6-difluoroaniline 429-430-0 444-14-4 Acute Tox. 4 * Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411

602-107-00-3 3,3,4,4-tetrafluoro-4-iodo-1-butene 439-500-2 33831-83-3 Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 H302 H315 H411 GHS07 GHS09 Wng H302 H315 H411

602-108-00-9 (2,3,5,6-tetrafluorophenyl)methanol 443-840-7 4084-38-2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS07 Wng H302 H319 H317

603-109-00-7 reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane 425-340-0 — Aquatic Chronic 4 H413 — H413

603-110-00-2 reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane 426-130-1 166301-21-9 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412

603-111-00-8 reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy- cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy- trans-cyclohexane 426-530-6 — Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410

603-112-00-3 cyclopentyl 2-phenylethyl ether 428-340-9 — Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410

603-113-00-9 6-glycidyloxynapht-1-yl oxymethyloxirane 429-960-2 27610-48-6 Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H341 H312 H315 H317 H412 GHS08 GHS07 Wng H341 H312 H315 H317 H412

603-114-00-4 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene 430-830-2 26912-64-1 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

603-115-00-X reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) 423-580-0 — STOT RE 2 * Aquatic Chronic 4 H373** H413 GHS08 Wng H373** H413

603-116-00-5 ( Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride 424-740-2 138271-16-6 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

603-182-00-5 reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin ( Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide 428-630-5 — Skin Sens. 1 H317 GHS07 Wng H317

603-188-00-8 reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene 426-970-9 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

603-190-00-9 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane 424-030-2 62406-73-9 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412

603-192-00-X ( E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol 423-240-1 125474-34-2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410

603-193-00-5 disodium 9,10-anthracenedioxide 426-030-8 46492-07-3 Skin Corr. 1A H314 GHS05 Dgr H314

603-194-00-0 2-(2-aminoethylamino)ethanol; (AEEA) 203-867-5 111-41-1 Repr. 1B Skin Corr. 1B Skin Sens. 1 H360Fd H361 H314 H317 GHS05 GHS08 GHS07 Dgr H360Fd H361 H314 H317 STOT SE 3; H335: C ≥ 5 %

603-200-00-1 1-pentanol; [1] 3-pentanol [2] 200-752-1 [1] 209-526-7 [2] 71-41-0 [1] 584-02-1 [2] Flam.

Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 H226 H332 H335 H315 GHS02 GHS07 Wng H226 H332 H335 H315

603-201-00-7 ( E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol 416-120-5 — Skin Irrit. 2 Aquatic Chronic 4 H315 H413 GHS07 Wng H315 H413

603-202-00-2 4,4,5,5,5-pentafluoropentan-1-ol 421-360-9 148043-73-6 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

603-203-00-8 (1 R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane 427-580-1 — Skin Irrit. 2 H315 GHS07 Wng H315

603-204-00-3 reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane 428-110-8 — Aquatic Chronic 3 H412 — H412

603-205-00-9 (1 S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride 426-200-1 172015-79-1 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H372** H302 H318 H317 H412 GHS05 GHS08 GHS07 Dgr H372** H302 H318 H317 H412

603-206-00-4 2,2-dichloro-1,3-benzodioxol 426-850-6 2032-75-9 Flam.

Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 H226 H314 H302 H317 GHS02 GHS05 GHS07 Dgr H226 H314 H302 H317 EUH014

603-207-00-X 2-isobutyl-2-isopropyl-1,3-dimethoxypropane 430-800-9 129228-21-3 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

603-208-00-5 1,2-diethoxyethane 211-076-1 629-14-1 Flam.

Liq. 2 Repr. 1A Eye Irrit. 2 H225 H360Df H319 GHS02 GHS08 GHS07 Dgr H225 H360Df H319 EUH019

603-209-00-0 spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2 R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3] - [1] - [2] - [3] - [1] 131929-60-7 [2] 131929-63-0 [3] Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M=10

603-210-00-6 2,4-diethyl-1,5-pentanediol 429-310-8 57987-55-0 Eye Dam. 1 H318 GHS05 Dgr H318

603-211-00-1 2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … % 221-221-0 3033-77-0 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H350 H341 H361f*** H312 H302 H373** H318 H317 H412 GHS05 GHS08 GHS07 Dgr H350 H341 H361f*** H312 H302 H373** H318 H317 H412 B

603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6- c]pyran; galaxolide; (HHCB) 214-946-9 1222-05-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

603-213-00-2 2-methoxy-2-methylbutane; tert-amyl methyl ether 213-611-4 994-05-8 Flam.

Liq. 2 Acute Tox. 4 * STOT SE 3 H225 H302 H336 GHS02 GHS07 Dgr H225 H302 H336

603-214-00-8 1,1-diisopropoxycyclohexane 413-740-8 1132-95-2 Skin Corr. 1B H314 GHS05 Dgr H314

603-215-00-3 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 418-330-2 162241-33-0 Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H201 H302 H373** H318 H317 H400 H410 GHS01 GHS05 GHS08 GHS07 GHS09 Dgr H201 H302 H373** H318 H317 H410

603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol 422-660-2 7480-35-5 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

603-217-00-4 2,4,6-tri- tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite 423-560-1 161717-32-4 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

603-220-00-0 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9 H-carbazol-4-yloxy)propan-2-ol 432-890-5 72955-94-3 Aquatic Chronic 4 H413 — H413

603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] 433-580-2 214353-17-0 Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H411

603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] 433-580-2 214353-17-0 Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 H350 H302 H314 H411 GHS05 GHS08 GHS07 GHS09 Dgr H350 H302 H314 H411

603-222-00-1 (2 R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane 433-820-6 118058-74-5 Eye Irrit. 2 H319 GHS07 Wng H319

603-223-00-7 2-cyclopentylidene cyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol 434-270-1 6261-30-9 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412

603-224-00-2 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane 435-790-1 297730-93-9 Aquatic Chronic 4 H413 — H413

603-225-00-8 erythromycin A9-oxime (E); (3 R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) 437-070-0 13127-18-9 Aquatic Chronic 2 H411 GHS09 H411

603-226-00-3 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol 444-500-0 1440-00-2 Aquatic Chronic 3 H412 — H412

603-227-00-9 α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate 445-060-2 203574-04-3 **** Aquatic Acute 1 Aquatic Chronic 1 **** H400 H410 **** GHS09 Wng **** H410

603-228-00-4 (+/–)-( R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane 419-620-1 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

603-229-00-X sodium ( Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate 420-800-7 — Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410

603-230-00-5 2,6,6,7,8,8-hexamethyldecahydro-2 H-indeno[4,5-b]furan 440-030-5 — Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 H315 H318 H413 GHS05 Dgr H315 H318 H413

603-231-00-0 ( S)-1,1-diphenyl-1,2-propanediol 443-220-6 — Aquatic Chronic 3 H412 — H412

603-232-00-6 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane 444-420-6 — Aquatic Chronic 4 H413 — H413

603-233-00-1 reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; ( E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; ( E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol 444-430-0 — Aquatic Chronic 2 H411 GHS09 H411

603-234-00-7 (1 R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene 444-480-3 — Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

604-071-00-4 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol 425-600-3 110726-28-8 Aquatic Chronic 4 H413 — H413

604-072-00-X 1,2-bis(phenoxymethyl)benzene 428-620-0 10403-74-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

604-073-00-5 ( E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol 428-010-4 82413-20-5 Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H360F*** H317 H400 H410 GHS08 GHS07 GHS09 Dgr H351 H360F*** H317 H410

604-074-00-0 tetrabromobisphenol-A; 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol 201-236-9 79-94-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol; 4- tert-octylphenol 205-426-2 140-66-9 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 M=10

604-076-00-1 phenolphthalein 201-004-7 77-09-8 Carc. 1B Muta. 2 Repr. 2 H350 H341 H361f*** GHS08 Dgr H350 H341 H361f*** Carc. 1A; H350: C ≥ 1 %

604-077-00-7 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol 419-750-9 98809-58-6 Aquatic Chronic 4 H413 — H413

604-079-00-8 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol 428-970-4 13595-25-0 Repr. 2 Skin Sens. 1 Aquatic Chronic 2 H361f*** H317 H411 GHS08 GHS09 Wng H361f*** H317 H411

604-080-00-3 4-fluoro-3-trifluoromethylphenol 432-560-0 61721-07-1 Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 H332 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H332 H314 H317 H411

604-081-00-9 1,1-bis(4-hydroxyphenyl)-1-phenylethane 433-130-5 1571-75-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

604-082-00-4 2-chloro-6-fluoro-phenol 433-890-8 2040-90-6 Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H340 H361f*** H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H340 H361f*** H302 H314 H317 H411

604-083-00-X 4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH 4Cl), pentachlorophosphorane and phenol 439-270-3 260408-02-4 Aquatic Chronic 4 H413 — H413

604-084-00-5 1-ethoxy-2,3-difluorobenzene 441-000-4 121219-07-6 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

604-087-00-1 reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol 433-640-8 — Pyr.

Sol. 1 Aquatic Chronic 4 H250 H413 GHS02 Dgr H250 H413 EUH044

604-089-00-2 2-methyl-5- tert-butylthiophenol 444-970-7 — Flam.

Liq. 3 Repr. 2 STOT RE 2 * Asp.

Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 GHS02 GHS08 GHS07 GHS09 Dgr H226 H361d*** H373** H304 H319 H315 H317 H336 H410

605-023-00-5 5-chloro-2-(4-chlorophenoxy)phenol 429-290-0 3380-30-1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

605-024-00-0 2-bromo-5-hydroxy-4-methoxybenzaldehyde 426-540-0 2973-59-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

605-032-00-4 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1 H-indol-2-yl]-(E)-2-propenal 425-370-4 93957-50-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

605-033-00-X reaction mass of: 3,7,11-trimethyl- cis-6,10-dodecadienal; 3,7,11-trimethyl- trans-6,10-dodecadienal 425-910-9 32480-08-3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410

605-034-00-5 reaction mass of: (1 RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1 RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1 RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde 429-860-9 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

605-035-00-0 ( E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal 426-330-9 177964-68-0 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H319 H317 H413 GHS07 Wng H319 H317 H413

605-036-00-6 2-bromomalonaldehyde 430-470-6 2065-75-0 Acute Tox. 4 * Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318

605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[( E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde 421-800-1 120578-03-2 Aquatic Chronic 4 H413 — H413

605-038-00-7 3-methyl-5-phenylpentan-1-al 433-900-0 55066-49-4 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H302 H315 H317 H411 GHS07 GHS09 Wng H302 H315 H317 H411

605-039-00-2 3,4-dihydroxy-5-nitrobenzaldehyde 441-810-8 116313-85-0 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317

606-074-00-6 reaction mass of: (1 R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2 R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene 425-570-1 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

606-090-00-3 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone 430-920-1 73096-98-7 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

606-093-00-X 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3 H-1,2,4-triazol-3-one 414-470-3 95885-13-5 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

606-094-00-5 N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one 417-460-7 — Aquatic Chronic 4 H413 — H413

606-095-00-0 ( R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one 421-830-3 49805-30-3 Acute Tox. 4 * Skin Sens. 1 H302 H317 GHS07 Wng H302 H317

606-096-00-6 3-(6- O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one 424-170-4 130603-71-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

606-097-00-1 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone 424-210-0 23911-85-5 Aquatic Chronic 4 H413 — H413

606-098-00-7 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione 431-220-9 158574-65-3 Aquatic Chronic 4 H413 — H413

606-099-00-2 5-methoxy-4'-(trifluoromethyl)valerophenone 425-000-1 61718-80-7 Aquatic Chronic 2 H411 GHS09 H411

606-100-00-6 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one 425-150-8 94723-86-1 Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 H360F*** H302 H317 H412 GHS08 GHS07 Dgr H360F*** H302 H317 H412

606-101-00-1 reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione 426-050-7 165038-51-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

606-102-00-7 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone 431-490-8 79876-59-8 Aquatic Chronic 2 H411 GHS09 H411

606-103-00-2 1-(4-( trans-4-ethylcyclohexyl)phenyl)ethanone 426-460-6 — Skin Sens. 1 H317 GHS07 Wng H317

606-104-00-8 1-(4-( trans-4-pentylcyclohexyl)phenyl)ethanone 426-830-7 78531-59-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

606-105-00-3 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione 431-500-0 226065-73-2 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

606-106-00-9 1-(4-( trans-4-butylcyclohexyl)phenyl)ethanone 427-320-7 83626-30-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

606-107-00-4 8-azaspiro[4.5]decane-7,9-dione 427-770-4 1075-89-4 Acute Tox. 3 * Aquatic Chronic 2 H301 H411 GHS06 GHS09 Dgr H301 H411

606-108-00-X 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone 436-710-6 756-13-8 Aquatic Chronic 3 H412 — H412

606-109-00-5 2-(4-methyl-3-pentenyl)anthraquinone 428-320-1 71308-16-2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 H302 H317 H314 GHS07 Wng H302 H317 H314

606-110-00-0 5-ethoxy-5 H-furan-2-one 428-330-4 2833-30-9 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 H314 H312 H302 H373** H317 GHS05 GHS08 GHS07 Dgr H314 H312 H302 H373** H317

606-111-00-6 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one 428-410-9 67014-36-2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

606-112-00-1 (4a R*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one 428-690-2 1668-86-6 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 H302 H319 H412 GHS07 Wng H302 H319 H412

606-113-00-7 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one 429-040-0 272460-97-6 Eye Dam. 1 Aquatic Chronic 4 H318 H314 GHS05 Dgr H318 H314

606-114-00-2 4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone 429-150-9 67887-47-2 Aquatic Chronic 4 H413 — H413

606-115-00-8 profoxydim (ISO); 2-{( EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one — 139001-49-3 Carc. 2 Repr. 2 Skin Sens. 1 H351 H361d H317 GHS08 GHS07 Wng H351 H361d H317

606-116-00-3 tepraloxydim (ISO); ( RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one — 149979-41-9 Carc. 2 Repr. 2 H351 H361fd GHS08 Wng H351 H361fd

606-117-00-9 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one 429-460-4 7078-98-0 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

606-118-00-4 N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine 429-640-2 52870-46-9 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H400 H410 GHS07 GHS09 Wng H319 H410

606-119-00-X ( E)-3-methyl-5-cyclopentadecen-1-one 429-900-5 — Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

606-120-00-5 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one 430-170-5 114625-74-0 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

606-121-00-0 (+)-(1 S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) 430-460-1 133636-82-5 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410

606-122-00-6 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one 430-820-8 114341-88-7 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H315 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373** H315 H318 H317 H410

606-123-00-1 4-hexadecyl-1-phenylpyrazolidin-3-one 430-840-7 — Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

606-124-00-7 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione 421-080-7 161462-35-7 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H373** H400 H410 GHS08 GHS09 Wng H373** H410

606-125-00-2 1-benzylimidazolidine-2,4-dione 421-340-1 6777-05-5 Acute Tox. 4 * H302 GHS07 Wng H302

606-126-00-8 1,4-bis(2,3-dihydroxypropylamino)anthraquinone 421-470-7 99788-75-7 Aquatic Chronic 2 H411 GHS09 H411

606-128-00-9 2,2'-(1,3-phenylene)bis[5-chloro-1 H-isoindole]-1,3(2H)-dione 422-650-8 148935-94-8 Aquatic Chronic 4 H413 — H413

606-129-00-4 5-amino-[2 S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2 S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 423-090-7 156732-13-7 Aquatic Chronic 4 H413 — H413

606-130-00-X 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone 423-860-2 56309-94-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

606-131-00-5 cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione 427-230-8 5571-36-8 Repr. 1B STOT RE 2 * Aquatic Chronic 2 H360F*** H373** H411 GHS08 GHS09 Dgr H360F*** H373** H411

606-132-00-0 (6β)-6,19-epoxyandrost-4-ene-3,17-dione 433-490-3 6563-83-3 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

606-134-00-1 androsta-1,4,9(11)-triene-3,17-dione 433-560-3 15375-21-0 Repr. 2 H361f*** GHS08 Wng H361f***

606-135-00-7 cyclohexadecanone 438-930-8 2550-52-9 Aquatic Chronic 4 H413 — H413

606-136-00-2 (3 S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone 444-350-6 133413-70-4 Eye Irrit. 2 Aquatic Chronic 4 H319 H413 GHS07 Wng H319 H413

606-137-00-8 trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione 444-750-0 211387-26-7 Aquatic Chronic 4 H413 — H413

606-138-00-3 (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone 444-800-1 141645-23-0 Flam.

Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H302 H373** H315 H318 H317 H400 H410 GHS02 GHS05 GHS08 GHS07 GHS09 Dgr H226 H302 H373** H315 H318 H317 H410 M=10

606-139-00-9 ( S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one 444-830-5 124379-29-9 Aquatic Chronic 4 H413 — H413

606-140-00-4 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one 444-860-9 474510-57-1 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H373** H400 H410 GHS08 GHS09 Wng H373** H410

606-141-00-X sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate 418-410-7 — Eye Irrit. 2 H319 GHS07 Wng H319

606-142-00-5 reaction mass of: (1 RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1 RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1 RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one 434-290-9 — Acute Tox. 4 * Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411

607-417-00-2 3-chloropropyl chloroformiate 425-770-9 628-11-5 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H331 H302 H373** H315 H318 H317 GHS06 GHS05 GHS08 Dgr H331 H302 H373** H315 H318 H317

607-428-00-2 tetrasodium ethylene diamine tetraacetate 200-573-9 64-02-8 Acute Tox. 4 * Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318

607-429-00-8 edetic acid; (EDTA) 200-449-4 60-00-4 Eye Irrit. 2 H319 GHS07 Wng H319

607-471-00-7 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane 429-280-6 151900-44-6 Aquatic Chronic 4 H413 — H413

607-473-00-8 pentaerythritol, dipentaerythritol, fatty acids, C 6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid 426-590-3 187412-41-5 Skin Sens. 1 H317 GHS07 Wng H317

607-477-00-X (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt 426-740-8 — Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

607-481-00-1 reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate 430-290-8 — Aquatic Chronic 4 H413 — H413

607-482-00-7 N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride 430-360-8 84793-24-8 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-483-00-2 1,2-benzenedicarboxylic acid; di-C 6-8-branched alkylesters, C7-rich 276-158-1 71888-89-6 Repr. 1B H360D*** GHS08 Dgr H360D***

607-484-00-8 ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1 H-isoindol-5-ylazo)phenyl]ethylamino}propionate 430-480-0 221452-67-1 Aquatic Chronic 4 H413 — H413

607-485-00-3 (3 S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate 430-510-2 — Aquatic Chronic 4 H413 — H413

607-486-00-9 potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate 402-110-8 110081-40-8 Aquatic Chronic 3 H412 — H412

607-491-00-6 reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) 427-140-9 — Carc. 2 H351 GHS08 Wng H351

607-504-00-5 diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate 422-670-7 — Repr. 1A Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H361f H301 H373** H400 H410 GHS06 GHS08 GHS09 Dgr H361f H301 H373** H410

607-509-00-2 2-phenoxyethyl 4-aminobenzoate 430-880-5 88938-23-2 Aquatic Chronic 2 H411 GHS09 H411

607-510-00-8 (2 S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide 427-200-4 76646-91-8 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317

607-511-00-3 reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid 423-750-4 — Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411

607-514-00-X potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate 427-240-2 134841-35-3 Skin Sens. 1 H317 GHS07 Wng H317

607-518-00-1 3-oxoandrost-4-ene-17-β-carboxylic acid 414-990-0 302-97-6 Repr. 1A Aquatic Chronic 4 H361f H413 GHS08 Dgr H361f H413

607-519-00-7 poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)- N-ethyl-N-(2-hydroxyethyl)ammonium acetate] 427-280-0 176429-27-9 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H335 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H335 H315 H318 H410

607-520-00-2 reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C 6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C 6-18)alkyl]-3H-imidazolium-N-ethylphosphate 427-740-0 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-521-00-8 tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate 429-270-1 136210-30-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

607-522-00-3 sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate 429-720-7 184246-86-4 Aquatic Chronic 3 H412 — H412

607-523-00-9 reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10’-diamino-6,6',13,13’-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10’[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate 430-200-7 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

607-524-00-4 tall oil 2-[(tetrahydro-2 H-pyran-2-yl) thio]ethyl esters 430-310-5 — Aquatic Chronic 4 H413 H413

607-525-00-X ( Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid 431-520-1 64485-90-1 Flam.

Sol. 1**** Carc. 2 Aquatic Chronic 3 H228 H351 H412 GHS02 GHS08 Dgr H228 H351 H412

607-528-00-6 ( S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid 430-900-2 192725-50-1 Eye Dam. 1 H318 GHS05 Dgr H318

607-529-00-1 benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate 426-070-6 67299-45-0 Aquatic Chronic 3 H412 — H412

607-530-00-7 reaction mass of isomers of: C 7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate 406-040-9 125643-61-0 Aquatic Chronic 4 H413 — H413

607-531-00-2 methyl 3-amino-4,6-dibromo-2-methyl-benzoate 425-190-6 119916-05-1 STOT RE 2 * Aquatic Chronic 2 H373** H411 GHS08 GHS09 Wng H373** H411

607-532-00-8 ( S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt 425-510-4 167944-94-7 Aquatic Chronic 3 H412 — H412

607-533-00-3 pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 414-910-4 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-534-00-9 ethyl 2-(3-benzoylphenyl)propanoate 414-920-9 60658-04-0 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 H301 H372** H317 H411 GHS06 GHS08 GHS09 Dgr H301 H372** H317 H411

607-535-00-4 potassium 4-iodo-2-sulfonato-benzoic acid 426-620-5 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

607-536-00-X (2,6-xylyloxy) acetic acid 430-910-7 13335-71-2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

607-537-00-5 isopropylammonium 2-(3-benzoylphenyl)propionate 417-970-1 — Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H372** H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H301 H312 H372** H318 H410

607-539-00-6 propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate 431-000-2 198705-81-6 Aquatic Chronic 4 H413 — H413

607-540-00-1 1-(mercaptomethyl)cyclopropylacetic acid 420-240-3 162515-68-6 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H314 H312 H302 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H312 H302 H317 H411

607-541-00-7 [(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) 421-940-1 28698-31-9 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

607-542-00-2 methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate 422-110-1 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-543-00-8 poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)- N-ethyl-N-(2-hydroxyethyl)ammonium acetate] 427-480-8 176429-22-4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H335 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H335 H315 H318 H410

607-544-00-3 ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate 427-490-2 158585-86-5 Aquatic Chronic 3 H412 — H412

607-545-00-9 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate 424-070-0 94346-09-5 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

607-546-00-4 reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate 424-290-7 188070-47-5 Skin Sens. 1 H317 GHS07 Wng H317

607-547-00-X 18-methylnonadecyl 2,2 -dimethylpropanoate 424-370-1 125496-22-2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic H315 H317 H413 GHS07 Wng H315 H317 H413

607-548-00-5 1-(2,4-dichlorophenyl)-2-(1 H-imidazol-1-yl)ethanone methanesulfonate 431-010-7 154486-26-7 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

607-549-00-0 methyl ( E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate 424-430-7 125778-19-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-550-00-6 2-amino-4-bromo-5-chlorobenzoic acid 424-700-4 — Eye Dam. 1 Aquatic Chronic 3 H318 H410 GHS05 Dgr H318 H410

607-551-00-1 tetrabutylammonium 2-amino-6-iodopurinate 424-710-9 156126-48-6 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H312 H302 H373** H315 H318 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H312 H302 H373** H315 H318 H317 H411

607-552-00-7 hexadecyl 3-amino-4-isopropoxybenzoate 424-830-1 — Aquatic Chronic 4 H413 — H413

607-553-00-2 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt 424-850-0 — Eye Dam. 1 H318 GHS05 Dgr H318

607-554-00-8 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid 424-870-1 27624-67-5 Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 H201 H318 H412 GHS01 GHS05 Dgr H201 H318 H412

607-555-00-3 1,1,3,3-tetramethylbutylperoxypivalate 424-980-8 22288-41-1 Flam.

Liq. 2 Org.

Perox.

D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H225 H242 H315 H317 H411 GHS02 GHS07 GHS09 Dgr H225 H242 H315 H317 H411

607-556-00-9 2-acetoxymethylene-4-acetylphenylacetate 425-160-2 24085-06-1 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373** H318 H317 H410

607-557-00-4 salt of: (1 S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid 425-210-3 169939-84-8 Skin Sens. 1 H317 GHS07 Wng H317

607-558-00-X 2 S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolane-2-carboxylate 425-250-1 147027-10-9 Aquatic Chronic 2 H411 GHS09 H411

607-559-00-5 coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid 425-400-6 179986-09-5 Aquatic Chronic 4 H413 — H413

607-560-00-0 ( R,S)-2-butyloctanedioic acid 431-210-4 50905-10-7 Eye Dam. 1 H318 GHS05 Dgr H318

607-561-00-6 sodium 4-hydroxy-3-( N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate 425-460-3 — Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

607-562-00-1 reaction mass of: (2 R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2 S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate 425-530-3 98769-75-6 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

607-563-00-7 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid 431-250-2 171850-30-9 Aquatic Chronic 2 H411 GHS09 H411

607-564-00-2 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate 425-730-0 51178-75-7 Skin Sens. 1 H317 GHS07 Wng H317

607-565-00-8 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 425-820-1 88150-42-9 Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H373** H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H301 H373** H318 H410

607-566-00-3 reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate 426-140-6 — Aquatic Chronic 4 H413 — H413

607-567-00-9 potassium 3-iodo-6-methylbenzenesulfonate 426-300-5 — Eye Dam. 1 H318 GHS05 Dgr H318

607-568-00-4 potassium 2-chloro-3-(benzyloxy)propionate 426-350-8 138666-92-9 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 H302 H373** H318 H317 GHS05 GHS08 GHS07 Dgr H302 H373** H318 H317

607-569-00-X reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate 426-470-0 — Skin Sens. 1 H317 GHS07 Wng H317

607-570-00-5 sodium (6 R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate 426-520-1 71420-85-4 Skin Sens. 1 H317 GHS07 Wng H317

607-571-00-0 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate 431-400-7 57374-49-9 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-572-00-6 diethyl thiophosphoryl ( Z)-(2-aminothiazol-4-yl)methoxyimino acetate 426-790-0 162208-27-7 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373** H317 H400 H410 GHS08 GHS07 GHS09 Wng H312 H302 H373** H317 H410

607-573-00-1 reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate 426-840-1 — Eye Dam. 1 H318 GHS05 Dgr H318

607-574-00-7 [1 R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate 426-890-4 77341-67-4 Eye Dam. 1 H318 GHS05 Dgr H318

607-575-00-2 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt 426-900-7 — STOT SE 3 Aquatic Chronic 3 H335 H412 GHS07 Wng H335 H412

607-576-00-8 branched, octyl 3-[3,5-di( tert-butyl)-4-hydroxyphenyl]propanoate 427-030-0 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-577-00-3 (2 R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate 427-100-0 — Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412

607-578-00-9 ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1 H-pyrazole-3-carboxylate 427-110-5 — Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 4 H302 H373** H413 GHS08 GHS07 Wng H302 H373** H413

607-579-00-4 diethyl[( p-ethoxyanilino)methylene]malonate 431-430-0 103976-28-9 Acute Tox. 4 * Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411

607-580-00-X ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 422-360-1 100491-29-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-581-00-5 ethyl 2-ethoxy-4-carboxymethylbenzoate 427-630-2 99469-99-5 Eye Dam. 1 H318 GHS05 Dgr H318

607-582-00-0 reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate 427-650-1 — Aquatic Chronic 3 H412 — H412

607-583-00-6 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid 427-680-5 188907-52-0 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

607-584-00-1 trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate 427-710-7 215612-56-9 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

607-585-00-7 strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate 427-930-3 — Skin Sens. 1 H317 GHS07 Wng H317

607-586-00-2 dodecyl 3-amino-4-chlorobenzoate 428-020-9 6195-20-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

607-587-00-8 ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate 428-030-3 67914-69-6 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H400 H410 GHS08 GHS07 GHS09 Wng H302 H373** H410

607-588-00-3 reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate 428-050-2 — Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

607-589-00-9 tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate 428-070-1 91788-83-9 STOT RE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H372** H302 H400 H410 GHS08 GHS07 GHS09 Dgr H372** H302 H410

607-590-00-4 hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate 428-140-1 210706-50-6 Aquatic Chronic 4 H413 — H413

607-591-00-X reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate 428-400-4 — Eye Dam.

H318 GHS05 Dgr H318

607-592-00-5 di(C 9-11-alkyl) cyclohexane-1,4-dicarboxylate 428-870-0 — Aquatic Chronic 4 H413 — H413

607-593-00-0 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate 429-000-2 159235-16-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

607-594-00-6 ethyl (1 S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate 429-020-1 204254-96-6 STOT RE 2 * Skin Sens. 1 H373** H317 GHS08 GHS07 Wng H373** H317

607-595-00-1 N-amidino-N-methylglycine-2-oxopropionate 429-120-5 208535-04-0 Eye Dam. 1 H318 GHS05 Dgr H318

607-596-00-7 ethyl 2-(4-phenoxyphenyl)lactate 429-220-9 132584-17-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

607-597-00-2 tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate 429-230-3 — Eye Dam. 1 H318 GHS05 Dgr H318

607-598-00-8 trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate 429-240-8 212652-59-0 Eye Dam. 1 H318 GHS05 Dgr H318

607-599-00-3 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate 431-610-9 68860-54-8 Org.

Perox.

D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H242 H317 H400 H410 GHS02 GHS07 GHS09 Dgr H242 H317 H410

607-600-00-7 (1 S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate 431-700-8 — Aquatic Chronic 2 H411 GHS09 H411

607-601-00-2 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate 429-370-5 220410-74-2 Acute Tox. 4 * H302 GHS07 Wng H302

607-602-00-8 ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate 429-680-0 122665-86-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

607-603-00-3 lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate 429-730-1 193562-37-7 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-604-00-9 guanidinium benzoate 429-820-0 26739-54-8 Acute Tox. 4 * H302 GHS07 Wng H302

607-605-00-4 methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate 429-890-2 144550-06-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-606-00-X ( Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid 430-100-3 86978-24-7 Acute Tox. 4 * H302 GHS07 Wng H302

607-607-00-5 reaction mass of: calcium bis(C 10-14 branched alkyl salicylate); calcium bis(C 18-30-alkyl salicylate); calcium C 10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C 10-14 branched alkyl phenolate); calcium bis (C 18-30-alkyl phenolate); calcium C 10-14 branched alkylphenolato-C18-30-alkyl phenolate; C 10-14 branched alkyl phenol; C 18-30-alkyl phenol 430-180-1 — Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

607-608-00-0 pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate 430-210-1 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-609-00-6 ethyl (3 R)-4-cyano-3-hydroxybutanoate 430-220-6 141942-85-0 Eye Irrit. 2 H319 GHS07 Wng H319

607-610-00-1 trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate 430-280-3 — Skin Sens. 1 H317 GHS07 Wng H317

607-611-00-7 methyl 3-amino-2,2,3-trimethylbutyrate 431-720-7 90886-53-6 Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 H314 H302 H412 GHS05 GHS07 Dgr H314 H302 H412

607-612-00-2 reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate 432-190-1 182176-52-9 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 H302 H373** H318 GHS05 GHS08 GHS07 Dgr H302 H373** H318

607-613-00-8 reaction mass of: succinic acid; monopersuccinic acid; dipersuccinic acid; monomethyl ester of succinic acid; monomethyl ester of persuccinic acid; dimethyl succinate; glutaric acid; monoperglutaric acid; diperglutaric acid; monomethyl ester of glutaric acid; monomethyl ester of perglutaric acid; dimethyl glutarate; adipic acid; monoperadipic acid; diperadipic acid; monomethyl ester of adipic acid; monomethyl ester of peradipic acid; dimethyl adipate; hydrogen peroxide; methanol; water 432-790-1 — Muta. 2 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * H341 H314 H332 H312 H302 GHS05 GHS08 GHS07 Dgr H341 H314 H332 H312 H302

607-614-00-3 2-(10-oxo-10 H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid 426-480-5 63562-33-4 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

607-615-00-9 reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance 431-120-5 — Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 H331 H302 H319 H317 GHS06 Dgr H331 H302 H319 H317

607-616-00-4 2,4-dichloro-5-fluorobenzoylchloride 428-390-1 86393-34-2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H335 H315 H318 H317 H412 GHS05 GHS07 Dgr H335 H315 H318 H317 H412

607-617-00-X bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate 430-700-5 10138-36-0 Skin Sens. 1 H317 GHS07 Wng H317

607-618-00-5 menadione sodium bisulfite; 2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt 204-987-0 130-37-0 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410

607-619-00-0 menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) 277-543-7 73581-79-0 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410

607-620-00-6 trisodium nitrilotriacetate 225-768-6 5064-31-3 Carc. 2 Acute Tox. 4 * Eye Irrit. 2 H351 H302 H319 GHS08 GHS07 Wng H351 H302 H319 Carc. 2; H351: C ≥ 5 %

607-621-00-1 milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] — — Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H400 H410 GHS07 GHS09 Wng H332 H302 H410 M=100

607-622-00-7 2-ethylhexyl-2-ethylhexanoate 231-057-1 7425-14-1 Repr. 2 H361d*** GHS08 Wng H361d***

607-623-00-2 diisobutyl phthalate 201-553-2 84-69-5 Repr. 1B H360Df GHS08 Dgr H360Df Repr. 1B; H360Df: C ≥ 25 % Repr. 2; H361f: 5 % ≤ C < 25 %

607-624-00-8 perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Lact.

Aquatic Chronic 2 H351 H360D*** H372** H332 H302 H362 H411 GHS08 GHS07 GHS09 Dgr H351 H360D*** H372** H332 H302 H362 H411

607-625-00-3 clodinafop-propargyl (ISO) — 105512-06-9 Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373** H317 H410 Skin Sens. 1; H317: C ≥ 0,001 % M=1

607-626-00-9 ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1 H-1,2,4-triazole-3-carboxylate 401-290-5 103112-35-2 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410

607-627-00-4 [(4 S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate 416-360-0 162221-28-5 Skin Sens. 1 H317 GHS07 Wng H317

607-628-00-X 4-oxo-4-( p-tolyl)butyric acid adduct with 4-ethylmorpholine 419-240-6 171054-89-0 Eye Dam. 1 H318 GHS05 Dgr H318

607-629-00-5 [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid 419-270-1 123599-82-6 Eye Irrit. 2 H319 GHS07 Wng H319

607-630-00-0 acrylic acid, 3-(trimethoxysilyl)propyl ester 419-560-6 4369-14-6 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H332 H314 H317 H412 GHS05 GHS07 Dgr H332 H314 H317 H412

607-631-00-6 reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate 442-300-8 — Skin Sens. 1 H317 GHS07 Wng H317

607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide 420-210-1 111244-14-5 Aquatic Chronic 4 H413 — H413

607-633-00-7 trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[( E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate 440-480-2 341026-59-3 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-634-00-2 ( S)-(–)-2-acetoxypropionylchloride; (1 S)-2-chloro-1-methyl-2-oxoethyl acetate 420-610-4 36394-75-9 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 H302 H314 H317 GHS05 GHS07 Dgr H302 H314 H317

607-635-00-8 trisodium N-(3-propionato)-l-aspartate 422-090-4 172737-80-3 Eye Dam. 1 H318 GHS05 Dgr H318

607-636-00-3 1-bromo-2-methylpropyl propionate 422-900-6 158894-67-8 Flam.

Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 H226 H351 H314 H317 GHS02 GHS05 GHS08 GHS07 Dgr H226 H351 H314 H317

607-637-00-9 disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate 423-730-5 250688-43-8 Eye Dam. 1 H318 GHS05 Dgr H318

607-638-00-4 2-hydroxybenzoic acid 2-butyloctyl ester 431-090-3 190085-41-7 Aquatic Chronic 4 H413 — H413

607-639-00-X 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate 431-770-1 216698-07-6 Aquatic Chronic 4 H413 — H413

607-641-00-0 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid 431-930-9 43028-69-9 Acute Tox. 4 * Skin Sens. 1 H302 H317 GHS07 Wng H302 H317

607-642-00-6 3,6,9-trithiaundecamethylene-1,11-dimethacrylate 432-210-7 141631-22-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

607-643-00-1 dimethyl (2 S)-2-hydroxysuccinate 432-310-0 617-55-0 Flam.

Liq. 3 Eye Dam. 1 Skin Sens. 1 H226 H318 H317 GHS02 GHS05 GHS07 Dgr H226 H318 H317

607-644-00-7 methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate 432-350-9 81752-87-6 Skin Irrit. 2 H315 GHS07 Wng H315

607-645-00-2 tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate 432-550-6 243858-01-7 Eye Dam. 1 H318 GHS05 Dgr H318

607-646-00-8 d-erythro-hexanoic acid 2,4-dideoxy-3,5- O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate 432-960-5 124655-09-0 Acute Tox. 4 * H302 GHS07 Wng H302

607-647-00-3 5-acetoxy-2-( R,S)butyryloxymethyl-1,3-oxathiolane 433-530-1 143446-73-5 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 H302 H317 H400 GHS07 GHS09 Wng H302 H317 H400

607-649-00-4 [3-(chlorocarbonyl)-2-methylphenyl]acetate 433-690-0 167678-46-8 Skin Corr. 1A Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317

607-650-00-X 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate 433-910-5 145153-52-2 Skin Sens. 1 H317 GHS07 Wng H317

607-651-00-5 sodium 2-(nonanoyloxy)benzenesulfonate 434-360-9 91125-43-8 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-652-00-0 ethyl N 2-dodecanoyl-l-argininate hydrochloride 434-630-6 60372-77-2 Eye Dam. 1 Aquatic Acute 1 H318 H400 GHS05 GHS09 Dgr H318 H400

607-653-00-6 tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate 434-840-8 225786-91-4 Aquatic Chronic 2 H411 GHS09 H411

607-654-00-1 ( S)-3-hydroxy-γ-butyrolactone 434-990-4 7331-52-4 Skin Sens. 1 H317 GHS07 Wng H317

607-655-00-7 ethyl 6,8-dichlorooctanoate 435-080-1 1070-64-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-656-00-2 sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid 435-350-7 141250-43-3 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

607-657-00-8 pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate 436-920-8 172399-10-9 Eye Dam. 1 H318 GHS05 Dgr H318

607-658-00-3 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt 440-770-9 371921-63-0 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

607-659-00-9 pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid 442-030-0 321912-47-4 Eye Dam. 1 H318 GHS05 Dgr H318

607-660-00-4 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt 442-230-8 321679-52-1 Eye Dam. 1 H318 GHS05 Dgr H318

607-661-00-X 1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate 442-850-9 114772-40-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

607-662-00-5 methyl 2-(acetylamino)-3-chloropropionate 442-860-3 87333-22-0 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

607-663-00-0 bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate 442-980-6 127474-91-3 Aquatic Chronic 4 H413 — H413

607-664-00-6 methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate 443-120-2 393509-79-0 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411

607-665-00-1 trans-methyl-2-ethyl-but-2-enoate 443-150-6 101226-85-1 Flam.

Liq. 3 H226 GHS02 Wng H226

607-666-00-7 (2 S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid 443-560-5 88784-33-2 Eye Irrit. 2 H319 GHS07 Wng H319

607-667-00-2 chloro-1-ethylcyclohexyl carbonate 444-950-8 99464-83-2 Muta. 2 Skin Sens. 1 H341 H317 GHS08 GHS07 Wng H341 H317

607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane 445-770-2 42031-28-7 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

607-669-00-3 methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate 445-990-9 376588-17-9 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

607-670-00-9 dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate 448-700-9 500791-70-8 STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373** H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H373** H318 H317 H410 M=10

607-671-00-4 diethyl 1,4-cyclohexanedicarboxylate 417-310-0 72903-27-6 Aquatic Chronic 2 H411 GHS09 H411

607-672-00-X reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate 419-000-0 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-673-00-5 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate 419-570-0 — Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

607-675-00-6 reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid 422-260-8 — Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

607-676-00-1 reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid 423-670-1 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

607-677-00-7 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate 424-660-8 — STOT RE 2 * Eye Dam. 1 Skin Sens. 1 H373** H318 H317 GHS05 GHS08 GHS07 Dgr H373** H318 H317

607-678-00-2 reaction mass of: ethyl (2 R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2 S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate 427-090-8 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-679-00-8 reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) 431-440-5 — Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411

607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate 432-810-9 — Aquatic Chronic 4 H413 — H413

607-681-00-9 reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate 432-910-2 — Aquatic Chronic 4 H413 — H413

607-682-00-4 complex reaction mass of Chinese gum rosin post reacted with acrylic acid 434-230-1 144413-22-9 Aquatic Chronic 4 H413 — H413

607-683-00-X reaction mass of: methyl 3-((1 E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1 Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) 435-450-0 — Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

607-684-00-5 alkenes, C 12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts 435-660-2 243662-67-1 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317

607-685-00-0 ammonium 2-cocoyloxyethanesulfonate 441-050-7 — Skin Irrit. 2 Eye Dam. 1 H315 H318 GHS05 Dgr H315 H318

607-686-00-6 6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) 441-550-5 — Self-react.

C **** Carc. 2 H242 H351 GHS02 GHS08 Dgr H242 H351

607-687-00-1 reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) 442-800-6 — Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

607-688-00-7 ( R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride 444-320-2 — Acute Tox. 4 * H302 GHS07 Wng H302

607-689-00-2 reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate („para-isomer“ including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate („meta-isomer“ including cis- and trans-isomers) 444-920-4 — Aquatic Chronic 3 H412 — H412

607-690-00-8 dimethyl[2 S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate 432-860-1 255387-46-3 Skin Sens. 1 H317 GHS07 Wng H317

607-691-00-3 magnesium salts, fatty acids, C 16-18 and C18 unsaturated, branched and linear 448-690-6 — Aquatic Chronic 4 H413 — H413

607-692-00-9 zinc salts, fatty acids, C 16-18 and C18 unsaturated, branched and linear 446-470-4 — Aquatic Chronic 4 H413 — H413

607-693-00-4 hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate 443-860-6 302776-68-7 Aquatic Chronic 4 H413 — H413

607-694-00-X ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate 443-870-0 163520-33-0 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410

608-020-00-7 diphenoxymethylenecyanamide 427-300-8 79463-77-7 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

608-032-00-2 acetamiprid (ISO); ( E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine — 135410-20-7 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

608-042-00-7 ( S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide 421-810-4 194602-27-2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411

608-044-00-8 2-cyclohexylidene-2-phenylacetonitrile 423-740-1 10461-98-0 Acute Tox. 4 * Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411

608-046-00-9 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile 425-310-7 77889-90-8 Aquatic Chronic 4 H413 — H413

608-047-00-4 2-piperidin-1-yl-benzonitrile 427-330-1 72752-52-4 Aquatic Chronic 2 H411 GHS09 H411

608-048-00-X 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile 427-450-4 152630-47-2 Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 H302 H373** H317 H411 GHS08 GHS07 GHS09 Wng H302 H373** H317 H411

608-049-00-5 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile 429-180-2 157362-53-3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

608-050-00-0 reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile 429-760-5 — Aquatic Chronic 4 H413 — H413

608-051-00-6 ( R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 430-760-2 219861-18-4 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

608-052-00-1 ( S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 430-770-7 128173-52-4 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

608-053-00-7 ( R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 430-780-1 103146-25-4 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

608-054-00-2 ( R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate 430-790-6 — Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411

608-055-00-8 fipronil (ISO); 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1 H-pyrazole-3-carbonitrile — 120068-37-3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H372** H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H372** H410 M=10

608-056-00-3 N-methyl-N-cyanomethylmorpholiniummethylsulfate 429-340-1 — Acute Tox. 4 * Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318

608-057-00-9 4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate 431-200-1 208538-34-5 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317

608-059-00-X 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1 H-pyrazole-3-carbonitrile 421-240-6 120068-79-3 Aquatic Chronic 2 H411 GHS09 H411

608-060-00-5 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile 421-300-1 138564-59-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

608-062-00-6 2-fluoro-4-hydroxybenzonitrile 422-810-7 82380-18-5 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

608-063-00-1 ( S)-α-hydroxy-3-phenoxy-benzeneacetonitrile 441-070-6 61826-76-4 Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H301 H318 H317 H410

608-064-00-7 cyanomethyltrimethylammoniummethylsulfate 433-720-2 — Aquatic Chronic 3 H412 — H412

609-069-00-7 musk ketone; 3,5-dinitro-2,6-dimethyl-4- tert-butylacetophenone; 4'- tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone 201-328-9 81-14-1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410

609-072-00-3 4-mesyl-2-nitrotoluene 430-550-0 1671-49-4 Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 H361f*** H302 H317 H412 GHS08 GHS07 Dgr H361f*** H302 H317 H412

609-073-00-9 lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine 427-850-9 — Skin Sens. 1 H317 GHS07 Wng H317

611-050-00-3 reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate 415-350-3 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-102-00-5 reaction product of: C.I.

Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid 424-500-7 — Aquatic Chronic 3 H412 — H412

611-139-00-7 reaction product of: C.I.

Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride 424-510-1 — Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411

611-141-00-8 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt 414-410-6 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

611-142-00-3 product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride 425-740-5 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-143-00-9 reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ- O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ- O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II) 428-260-4 — Eye Dam. 1 H318 GHS05 Dgr H318

611-144-00-4 reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt 429-070-4 214362-06-8 Eye Dam. 1 H318 GHS05 Dgr H318

611-145-00-X reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt 429-440-5 — Eye Dam. 1 H318 GHS05 Dgr H318

611-146-00-5 reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate 430-070-1 — Aquatic Chronic 2 H411 GHS09 H411

611-147-00-0 sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate 430-090-0 205764-96-1 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

611-148-00-6 reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol 429-590-1 — Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

611-149-00-1 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate 427-570-7 193486-83-8 Aquatic Chronic 2 H411 GHS09 H411

611-150-00-7 tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate 440-460-3 — Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412

611-151-00-2 chrysoidine; 4-(phenylazo)benzene-1,3-diamine 207-803-7 495-54-5 Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H315 H400 H410 GHS08 GHS07 GHS09 Wng H341 H302 H315 H410

611-152-00-8 chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine- p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] 208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] 532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H315 H318 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H341 H302 H315 H318 H410

611-153-00-3 chrysoidine C 10-14-alkyl derivatives; benzenesulfonic acid, mono-C 10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] 286-946-7 [1] 304-236-8 [2] 85407-90-5 [1] 94247-67-3 [2] Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 H341 H302 H315 H318 GHS05 GHS08 GHS07 Dgr H341 H302 H315 H318

611-154-00-9 trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate 403-670-6 92408-46-3 Aquatic Chronic 3 H412 — H412

611-155-00-4 4,4'-oxybis(benzenesulfonylazide) 431-850-4 7456-68-0 Expl. 1.1**** STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H201 H373** H400 H410 GHS01 GHS08 GHS09 Dgr H201 H373** H410

611-156-00-X triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate 432-270-4 221354-37-6 Repr. 2 STOT RE 2 * Aquatic Chronic 2 H361f*** H373** H411 GHS08 GHS09 Wng H361f*** H373** H411

611-157-00-5 benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[( E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate 432-590-4 243869-48-9 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412

611-158-00-0 reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride 421-520-8 — **** Aquatic Chronic 4 **** H413 **** **** H413

611-159-00-6 disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate 421-880-6 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-160-00-1 reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane; reaction product of 1,1,1-tris( p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris( p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) 422-760-6 — **** Aquatic Chronic 4 **** H413 **** **** H413

611-161-00-7 trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato- O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) 423-100-1 — Eye Dam. 1 H318 GHS05 Dgr H318

611-162-00-2 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) 429-600-4 — Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

611-163-00-8 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate 429-610-9 — Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411

611-164-00-3 reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile; 2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2,2'-dimethyl-2,2'-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile) 429-710-2 — Self React D Acute Tox. 4 * Aquatic Chronic 2 H242 H302 H411 GHS02 GHS07 GHS09 Dgr H242 H302 H411

611-165-00-9 reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 431-830-5 — Aquatic Chronic 3 H412 — H412

611-166-00-4 reaction mass of: pentasodium 4-amino-5-hydroxy-3-{( E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{( E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{( E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 432-100-9 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-167-00-X sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II) 435-240-9 — Aquatic Chronic 3 H412 — H412

611-168-00-5 reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 435-440-6 — Eye Dam. 1 H318 GHS05 Dgr H318

611-169-00-0 sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate 435-800-2 — Aquatic Chronic 3 H412 — H412

611-170-00-6 reaction mass of: trisodium 2-((1-(2-hydroxy-κ- O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N)-1-phenylmethyl)azo-κ-2 N)-4-sulfonatobenzoate(5-)-κ-1 O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ- O-phenylazo-κ-N)-1-phenylmethyl)azo-κ-2 N)-4-sulfonatobenzoate-κ-1 O-(5-))cuprate(II) 435-880-9 — Aquatic Chronic 3 H412 — H412

611-171-00-1 reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate 436-890-6 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-172-00-7 reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate 438-310-7 — Self-react.

C**** Repr. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 H242 H361f*** H302 H373** H412 GHS02 GHS08 GHS07 Dgr H242 H361f*** H302 H373** H412

611-173-00-2 reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt 440-510-4 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

611-174-00-8 reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt 442-290-5 457624-86-1 Eye Dam. 1 H318 GHS05 Dgr H318

611-175-00-3 reaction mass of: trisodium 5-{4-chloro-6-[ N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[ N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[ N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[ N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate 444-050-5 — Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

611-176-00-9 2,6-bis(2,3,4-trihydroxybenzyl)- p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate 444-250-2 — Self-react.

C**** Aquatic Chronic 2 H242 H411 GHS02 GHS09 Dgr H242 H411

611-177-00-4 reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III) 444-290-0 508202-43-5 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

611-178-00-X reaction mass of: pentasodium 4-amino-5-hydroxy-3-{( E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{( E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[( E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[( E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[( E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[( E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 445-280-9 — Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

611-179-00-5 reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate 450-010-8 — Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

611-180-00-0 iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts 417-850-7 — Aquatic Chronic 2 H411 GHS09 H411

612-057-01-1 piperazine; [liquid] 203-808-3 110-85-0 Repr. 2 Skin Corr. 1B Resp.

Sens. 1 Skin Sens. 1 H361fd H314 H334 H317 GHS05 GHS08 Dgr H361fd H314 H334 H317

612-122-01-4 hydroxylamine … % [≤ 55 % in aqueous solution] 232-259-2 7803-49-8 Met.

Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 B

612-169-00-3 bis( N-methyl-N-phenylhydrazine)sulfate 423-170-1 618-26-8 Flam.

Liq. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H225 H372** H302 H318 H317 H400 H410 GHS02 GHS05 GHS08 GHS07 GHS09 Dgr H225 H372** H302 H318 H317 H410

612-203-00-7 C 8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: < 3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: < 3 %) 417-360-3 — Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 H312 H302 H315 GHS07 Wng H312 H302 H315

612-208-00-4 N-methylbenzene-1,2-diammonium hydrogen phosphate 424-460-0 — Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

612-216-00-8 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt 425-870-2 19450-38-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

612-219-00-4 (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride 402-200-7 — Aquatic Chronic 3 H412 — H412

612-220-00-X N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine 431-060-1 153719-38-1 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412

612-221-00-5 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride 429-560-8 4274-38-8 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 H314 H332 H312 H302 H373** H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H314 H332 H312 H302 H373** H317 H400

612-222-00-0 cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine 425-080-8 104860-26-6 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373** H318 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H312 H302 H373** H318 H410

612-223-00-6 N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine 425-300-2 186450-73-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

612-224-00-1 N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine 426-150-0 121246-28-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

612-225-00-7 1,4,7,10-tetraazacyclododecane 425-450-9 294-90-6 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H314 H312 H302 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H312 H302 H410

612-226-00-2 3-(2'-phenoxyethoxy)propylamine 427-870-8 6903-18-0 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H302 H315 H318 H412 GHS05 GHS07 Dgr H302 H315 H318 H412

612-227-00-8 benzyl- N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride 428-290-8 120606-08-8 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410

612-228-00-3 reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine 414-340-6 — Flam.

Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H226 H332 H312 H302 H371 H318 H317 H412 GHS02 GHS05 GHS08 GHS07 Dgr H226 H332 H312 H302 H371 H318 H317 H412

612-229-00-9 mepanipyrim; 4-methyl- N-phenyl-6-(1-propynyl)-2-pyrimidinamine — 110235-47-7 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410

612-230-00-4 N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide 431-530-4 — Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410

612-231-00-X 3-((C 12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride 427-370-1 164288-56-6 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

612-232-00-5 reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid 430-410-9 186148-38-9 Aquatic Chronic 3 H412 — H412

612-237-00-2 hydroxylammonium hydrogensulfate; hydroxylamine sulfate (1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] Expl. 1.1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H201 H351 H312 H302 H373** H319 H315 H317 H400 HS01 GHS08 GHS07 GHS09 Dgr H201 H351 H312 H302 H373** H319 H315 H317 H400 T

612-238-00-8 (3-chloro-2-hydroxypropyl) trimethylammonium chloride … % 222-048-3 3327-22-8 Carc. 2 Aquatic Chronic 3 H351 H412 GHS08 Wng H351 H412 B

612-239-00-3 biphenyl-3,3',4,4'-tetrayltetraamine; diaminobenzidine 202-110-6 91-95-2 Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341

612-240-00-9 pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline — 53112-28-0 Aquatic Chronic 2 H411 GHS09 H411

612-241-00-4 piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] Repr. 2 Eye Irrit. 2 Skin Irrit. 2 Resp.

Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H361fd H319 H315 H334 H317 H412 GHS08 Dgr H361fd H319 H315 H334 H317 H412

612-242-00-X cyprodinil (ISO); 4-cyclopropyl-6-methyl- N-phenylpyrimidin-2-amine — 121552-61-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10

612-243-00-5 (1 S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate 420-560-3 79617-97-3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 M=10

612-244-00-0 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride 421-310-6 87691-88-1 Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f*** H302 H319 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f*** H302 H319 H317 H410

612-245-00-6 2-ethylphenylhydrazine hydrochloride 421-460-2 19398-06-2 Carc. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H372** H302 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H351 H372** H302 H318 H317 H410 M=10

612-246-00-1 (2-chloroethyl)(3-hydroxypropyl)ammonium chloride 429-740-6 40722-80-3 Carc. 1B Muta. 1B STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 H350 H340 H373** H317 H412 GHS08 GHS07 Dgr H350 H340 H373** H317 H412

612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide 423-530-8 152828-23-4 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 3 H372** H302 H412 GHS08 GHS07 Dgr H372** H302 H412

612-248-00-2 reaction product of diphenylamine, phenothiazine, and alkenes, branched (C 8-10, C9-rich) 439-540-0 — Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413

612-249-00-8 4-[(3-chlorophenyl)(1 H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride 425-030-5 159939-85-2 Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H361f*** H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H361f*** H302 H314 H317 H411

612-250-00-3 chloro- N,N-dimethylformiminium chloride 425-970-6 3724-43-4 Repr. 1B Acute Tox. 4 * Skin Corr. 1A H360D*** H302 H314 GHS05 GHS08 GHS07 Dgr H360D*** H302 H314 EUH014

612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 426-020-3 51229-78-8 Flam.

Sol. 2 Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H228 H361d*** H302 H315 H317 H411 GHS02 GHS08 GHS07 GHS09 Wng H228 H361d*** H302 H315 H317 H411

612-252-00-4 imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)- N-nitroimidazolidin-2-ylidenamine 428-040-8 138261-41-3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410

612-253-00-X 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3 H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] 429-400-7 199327-61-2 Aquatic Chronic 3 H412 — H412

612-253-01-7 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3 H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] 429-400-7 199327-61-2 Repr. 1B Aquatic Chronic 3 H360D*** H412 GHS08 Dgr H360D*** H412

612-254-00-5 reaction products of diisopropanolamine with formaldehyde (1:4) 432-440-8 220444-73-5 Carc. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H351 H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H351 H302 H314 H317 H411

612-255-00-0 1-(3-methoxypropyl)-4-piperidinamine 431-950-8 179474-79-4 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 H312 H302 H314 H412 GHS05 GHS07 Dgr H312 H302 H314 H412

612-256-00-6 benzyl( S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate 427-470-3 137864-22-3 Acute Tox. 4 * Skin Sens. 1 H302 H317 GHS07 Wng H302 H317

612-257-00-1 tripropylammonium dihydrogenphosphate 433-700-3 35687-90-2 Acute Tox. 4 * H302 GHS07 Wng H302

612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine 437-720-3 227085-51-0 Eye Dam. 1 H318 GHS05 Dgr H318

612-261-00-3 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline 441-190-9 121451-05-6 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=10

612-265-00-5 bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate 444-360-0 191617-13-7 Aquatic Chronic 3 H412 — H412

612-266-00-0 3-chloro-4-(3-fluorobenzyloxy)aniline 445-590-4 202197-26-0 Muta. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H373** H400 H410 GHS08 GHS07 GHS09 Wng H341 H302 H373** H410

612-267-00-6 bis(hydrogenated tallow C 16-18-alkyl)hydroxylamine 418-370-0 — Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

612-269-00-7 reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1 H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1 H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline 420-720-2 — Aquatic Chronic 4 H413 — H413

612-270-00-2 ( S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride 433-010-2 — Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412

612-271-00-8 reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate 434-970-5 160987-57-5 Aquatic Chronic 4 H413 — H413

612-272-00-3 ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate 435-210-5 — Aquatic Chronic 2 H411 GHS09 H411

612-273-00-9 alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride 435-650-8 — Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H410

612-274-00-4 ( R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate 445-750-3 — Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412

612-275-00-X fatty acids, C 18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil 447-880-6 206565-89-1 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 M=10

612-276-00-5 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts 451-430-4 500717-36-2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

612-277-00-0 reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium 451-440-9 586372-44-3 Eye Dam. 1 H318 GHS05 Dgr H318

612-278-00-6 ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 214-984-6 1239-45-8 Muta. 2 Acute Tox. 2 * Acute Tox. 4 * H341 H330 H302 GHS06 GHS08 Dgr H341 H330 H302

612-279-00-1 ( R,S)-2-amino-3,3-dimethylbutane amide 447-860-7 144177-62-8 Repr. 2 STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H361f*** H373** H319 H315 H317 GHS08 GHS07 Wng H361f*** H373** H319 H315 H317

612-280-00-7 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine 205-057-7 132-32-1 Carc. 1B H350 GHS08 Dgr H350 H

613-116-01-4 tolylfluanid (ISO); dichloro- N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 211-986-9 731-27-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H319 H335 H315 H317 H400 GHS07 GHS09 Wng H319 H335 H315 H317 H400 M=10

613-161-00-2 2,4-diamino-6-hydroxymethylpteridinehydrobromide 430-620-0 76145-91-0 STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 H373** H317 H412 GHS08 GHS07 Wng H373** H317 H412

613-162-00-8 (6 R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide 423-260-0 100988-63-4 Muta. 2 Skin Sens. 1 Aquatic Chronic 2 H341 H317 H411 GHS08 GHS07 GHS09 Wng H341 H317 H411

613-187-00-4 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene 410-530-8 — Skin Sens. 1 H317 GHS07 Wng H317

613-192-00-1 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza- cis-bicyclo[3.1.0]hexane 426-750-2 151860-15-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

613-198-00-4 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine 415-500-8 145963-84-4 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 H302 H373** H412 GHS08 GHS07 Wng H302 H373** H412

613-229-00-1 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine 411-930-5 106917-31-1 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410

613-231-00-2 2,6-diamino-3-((pyridine-3-yl)azo)pyridine 421-430-9 28365-08-4 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 H302 H373** H411 GHS08 GHS07 GHS09 Wng H302 H373** H411

613-232-00-8 3-(benzo[ b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide 431-030-6 163269-30-5 Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H373** H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H331 H373** H318 H410

613-234-00-9 imidazo[1,2-b]pyridazin hydrochloride 431-510-5 18087-70-2 Acute Tox. 4 * Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319

613-235-00-4 2,3-dihydro-2,2-dimethyl-1 H-perimidine 424-060-6 6364-17-6 Acute Tox. 4* STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373** H317 H410

613-236-00-X 2-chloro-3-trifluoromethylpyridine 424-520-6 65753-47-1 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Chronic 3 H311 H301 H372** H314 H412 GHS06 GHS05 GHS08 Dgr H311 H301 H372** H314 H412

613-237-00-5 6- tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine 424-950-4 133949-92-5 Aquatic Chronic 4 H413 — H413

613-238-00-0 sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate 430-890-1 81992-66-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410

613-239-00-6 2-[3-(methylamino)propyl]-1 H-benzimidazole 425-760-4 64137-52-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412

613-241-00-7 3-(2 H-tetrazol-5-yl)pyridine 426-810-8 3250-74-6 Eye Dam. 1 H318 GHS05 Dgr H318

613-242-00-2 reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts 426-860-0 191877-09-5 Eye Dam. 1 H318 GHS05 Dgr H318

613-243-00-8 4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) 427-350-0 182235-14-9 Aquatic Chronic 2 H411 GHS09 H411

613-244-00-3 5,7-dichloro-4-hydroxyquinoline 427-420-0 21873-52-9 Aquatic Chronic 2 H411 GHS09 H411

613-245-00-9 2-fluoro-6-trifluoromethylpyridine 428-100-3 94239-04-0 Flam.

Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 H226 H332 H302 H412 GHS02 GHS07 Wng H226 H332 H302 H412

613-246-00-4 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine 428-200-7 103577-66-8 Aquatic Chronic 3 H412 — H412

613-247-00-X 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole 428-910-7 107786-36-7 Aquatic Chronic 4 H413 — H413

613-248-00-5 3,4-dimethyl-1 H-pyrazole 429-130-1 2820-37-3 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

613-249-00-0 1-(2-hydroxyethyl)-1 H-pyrazol-4,5-diyldiammoniumsulfate 429-300-3 155601-30-2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411

613-250-00-6 reaction mass of: carbonato-bis- N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato- N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl- N-hydroxyethyl 1,3-oxazolidine 429-990-6 — Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

613-251-00-1 ( R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole 430-560-5 180637-89-2 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 H302 H373** H318 H317 GHS05 GHS08 GHS07 Dgr H302 H373** H318 H317

613-253-00-2 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C 1-12 and the sum to C13, average degree of ethoxylation is 3,5) 430-580-4 — Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 EUH019

613-254-00-8 forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea — 68157-60-8 Carc. 2 Aquatic Chronic 2 H351 H411 GHS08 GHS09 Wng H351 H411

613-255-00-3 reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II) 424-270-8 — Eye Dam. 1 H318 GHS05 Dgr H318

613-256-00-9 3'5'-anhydro thymidine 425-810-5 38313-48-3 Aquatic Chronic 3 H412 — H412

613-257-00-4 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate 426-400-9 170222-39-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

613-258-00-X reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt 427-730-6 202420-04-0 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412

613-259-00-5 reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1 R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1 R)-trans-chrysanthemate 428-790-6 72963-72-5 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410

613-260-00-0 (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1 H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin 430-730-9 — Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410

613-261-00-6 pyrazole-1-carboxamidine monohydrochloride 429-520-1 4023-02-3 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H373** H318 H317 H412 GHS05 GHS08 GHS07 Dgr H302 H373** H318 H317 H412

613-262-00-1 disodium ( E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene 427-310-2 180850-95-7 Eye Dam. 1 H318 GHS05 Dgr H318

613-263-00-7 monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate 429-570-2 — Skin Sens. 1 H317 GHS07 Wng H317

613-266-00-3 2-chloro-5-chloromethylthiazole 429-830-5 105827-91-6 Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H311 H314 H302 H317 H411 GHS06 GHS05 GHS09 Dgr H311 H314 H302 H317 H411

613-267-00-9 thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene- N-nitroamine 428-650-4 153719-23-4 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=10

613-268-00-4 (4a S-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine 425-930-8 151213-39-7 Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 H314 H332 H302 H373** H411 GHS05 GHS08 GHS07 GHS09 Dgr H314 H332 H302 H373** H411

613-269-00-X 2-thiazolidinylidenecyanamide 427-720-1 26364-65-8 Acute Tox. 4* STOT RE 2 * Aquatic Chronic 3 H302 H373** H412 GHS08 GHS07 Wng H302 H373** H412

613-270-00-5 5-amino- N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide 428-150-6 113171-13-4 Aquatic Chronic 3 H412 — H412

613-271-00-0 tritosulfuron (ISO) (containing ≤ 0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT) — 142469-14-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10

613-272-00-6 pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate — — Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H315 H400 H410 GHS06 GHS09 Dgr H331 H315 H410 M=100

613-273-00-1 tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4 H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine 427-600-9 192439-46-6 Aquatic Chronic 2 H411 GHS09 H411

613-274-00-7 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate 427-400-1 140623-89-8 Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H302 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H302 H317 H410

613-275-00-2 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4 H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride 424-530-0 93076-03-0 Acute Tox. 3 * STOT SE 2 STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H301 H371** H373** H318 H317 H411 GHS06 GHS05 GHS08 GHS09 Dgr H301 H371 H373** H318 H317 H411

613-276-00-8 1-(2-chlorophenyl)-1,2-dihydro-5 H-tetrazol-5-one 426-110-2 98377-35-6 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

613-277-00-3 (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1 H-pyrazol-5-one 427-070-9 — Aquatic Chronic 4 H413 — H413

613-278-00-9 (3-aminophenyl)pyridin-3-ylmethanone 428-230-0 79568-06-2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H373** H400 H410 GHS08 GHS09 Wng H373** H410

613-279-00-4 2-ethyl-2,3-dihydro-2-methyl-1 H-perimidine 424-380-6 43057-68-7 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H400 H410 GHS08 GHS07 GHS09 Wng H302 H373** H410

613-280-00-X tetrahydro-1,3-dimethyl-1 H-pyrimidin-2-one; dimethyl propyleneurea 230-625-6 7226-23-5 Repr. 2 Acute Tox. 4 * Eye Dam. 1 H361f*** H302 H318 GHS05 GHS08 GHS07 Dgr H361f*** H302 H318

613-281-00-5 quinoline 202-051-6 91-22-5 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H350 H341 H312 H302 H319 H315 H411 GHS08 GHS07 GHS09 Dgr H350 H341 H312 H302 H319 H315 H411

613-282-00-0 triticonazole (ISO); ( RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol — 131983-72-7 Aquatic Chronic 2 H411 GHS09 H411

613-283-00-6 ketoconazole; 1-[4-[4-[[(2 SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone 265-667-4 65277-42-1 Repr. 1B Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H360F*** H301 H373** H400 H410 GHS06 GHS08 GHS09 Dgr H360F*** H301 H373** H410

613-284-00-1 metconazole (ISO); (1 RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol — 125116-23-6 Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 H361d*** H302 H411 GHS08 GHS07 GHS09 Wng H361d*** H302 H411

613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] 219-989-7 [1] 219-989-7 [2] 2592-95-2 [1] 123333-53-9 [2] Expl. 1.3 H203 GHS01 Dgr H203

613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2 183196-57-8 Skin Sens. 1 H317 GHS07 Wng H317

613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] 418-260-2 183196-57-8 Repr. 1B Skin Sens. 1 H360D*** H317 GHS08 GHS07 Dgr H360D*** H317

613-287-00-8 1-(3-iodo-4-aminobenzyl)-1 H-1,2,4-triazole 419-540-7 160194-26-3 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

613-288-00-3 1,3-bis(dimethylcarbamoyl)-imidazolium chloride 420-930-4 135756-61-5 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

613-289-00-9 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1 H-pyrazole 432-020-4 142623-48-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

613-290-00-4 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3 H)-one hydrochloride 432-470-1 189012-93-9 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410

613-291-00-X 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3 H-1,2,4-triazol-3-one 434-820-9 106461-41-0 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H373** H400 H410 GHS08 GHS09 Wng H373** H410

613-292-00-5 N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine 435-010-8 26157-73-3 Muta. 2 Aquatic Chronic 3 H341 H412 GHS08 Wng H341 H412

613-293-00-0 2-(4- tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester 448-050-6 444065-11-6 Aquatic Chronic 4 H413 — H413

613-294-00-6 2-hexyldecanoic acid [4-(6- tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester 448-260-8 379268-96-9 Aquatic Chronic 4 H413 — H413

613-295-00-1 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride 448-720-8 363138-44-7 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

613-296-00-7 pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate 418-270-7 — Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

613-297-00-2 5-(2-bromophenyl)-2- tert-butyl-2H-tetrazole 420-820-6 — Flam.

Liq. 3 Acute Tox. 4 * Aquatic Chronic 2 H226 H302 H411 GHS02 GHS07 GHS09 Wng H226 H302 H411

613-298-00-8 bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1 H-pyridin-2-one)ethylene dilactate 421-560-6 — STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 H373** H318 H411 GHS05 GHS08 GHS09 Dgr H373** H318 H411

613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt 422-610-1 — Eye Dam. 1 H318 GHS05 Dgr H318

613-300-00-7 1-imidazol-1-yl-octadecan-2-ol 434-120-3 — Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

613-301-00-2 dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate 443-910-7 — Aquatic Chronic 4 H413 — H413

613-302-00-8 disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate 432-980-4 243858-60-8 Eye Dam. 1 H318 GHS05 Dgr H318

613-303-00-3 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine 429-800-1 95737-68-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

613-304-00-9 5,6-dihydroxy-2,3-dihydro-1 H-indolium bromide 421-170-6 138937-28-7 Acute Tox. 4 * Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318

613-305-00-4 2-(2-hydroxy-4-octyloxyphenyl)-2 H-benzotriazole 448-630-9 3147-77-1 Aquatic Chronic 4 H413 — H413

613-306-00-X (2,5-dioxopyrrolidin-1-yl)-9 H-fluoren-9-ylmethyl carbonate 433-520-5 82911-69-1 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411

613-307-00-5 clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine — 210880-92-5 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=10

613-308-00-0 2-amino-5-methylthiazole 423-800-5 7305-71-7 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 H302 H373** H400 H410 GHS08 GHS07 GHS09 Wng H302 H373** H410

613-309-00-6 1-methyl-3-phenyl-1-piperazine 431-180-2 5271-27-2 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H312 H302 H315 H318 H412 GHS05 GHS07 Dgr H312 H302 H315 H318 H412

613-310-00-1 (-)(3 S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride 432-360-3 105813-13-6 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410

613-311-00-7 methyl-5-nitrophenyl-guanidine 435-500-1 152460-07-6 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H302 H319 H317 H412 GHS07 Wng H302 H319 H317 H412

613-312-00-2 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride 420-200-5 — Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412

613-313-00-8 2-(4-(4-(3-pyridinyl)-1 H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione 442-780-9 173838-67-0 Aquatic Chronic 3 H412 — H412

613-314-00-3 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one 443-770-7 7693-82-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

613-315-00-9 tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate 430-390-1 — Acute Tox. 4 * Aquatic Chronic 3 H332 H412 GHS07 Wng H332 H412

613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate); (TAZ) 257-765-0 52234-82-9 Muta. 2 Eye Dam. 1 Skin Sens. 1 H341 H318 H317 GHS05 GHS08 GHS07 Dgr H341 H318 H317 H

615-033-00-1 reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097) 430-980-9 — Aquatic Chronic 4 H413 — H413

615-034-00-7 reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) 430-750-8 — Aquatic Chronic 4 H413 — H413

615-035-00-2 reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) 430-930-6 122886-55-9 Aquatic Chronic 4 H413 — H413

615-036-00-8 reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) 430-940-0 — Aquatic Chronic 4 H413 — H413

615-037-00-3 reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) 430-950-5 — Aquatic Chronic 4 H413 — H413

615-038-00-9 reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) 430-960-1 — Aquatic Chronic 4 H413 — H413

615-039-00-4 reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) 430-970-4 — Aquatic Chronic 4 H413 — H413

615-044-00-1 4-chlorophenylisocyanate 203-176-9 104-12-1 Acute Tox. 2 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp.

Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H302 H335 H315 H318 H334 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H330 H302 H335 H315 H318 H334 H410

615-045-00-7 4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) 420-530-1 — Resp.

Sens. 1 Skin Sens. 1 Aquatic Chronic 4 H334 H317 H413 GHS08 Dgr H334 H317 H413

616-107-00-6 cinidon ethyl (ISO); ethyl ( Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate — 142891-20-1 Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H317 H410

616-122-00-8 methyl-neodecanamide 414-460-9 105726-67-8 Acute Tox. 4 * H302 GHS07 Wng H302

616-126-00-X 1-methyl-4-nitro-3-propyl-1 H-pyrazole-5-carboxamide 423-960-6 139756-01-7 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 H302 H373** H412 GHS08 GHS07 Wng H302 H373** H412

616-131-00-7 1-aminocyclopentanecarboxamide 422-950-9 17193-28-1 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 H372** H302 H318 GHS05 GHS08 GHS07 Dgr H372** H302 H318

616-136-00-4 reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1) 430-380-7 — Aquatic Chronic 2 H411 GHS09 H411

616-137-00-X 4-dichloroacetyl-1-oxa-4-azaspiro[4,5]decane 401-130-4 71526-07-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

616-138-00-5 benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide 431-600-4 112226-61-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

616-139-00-0 (3 S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide 420-380-5 136465-81-1 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412

616-140-00-6 N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea] 429-380-1 133336-92-2 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

616-141-00-1 zoxamide (ISO); ( RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide — 156052-68-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10

616-144-00-8 3,4-dichloro- N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide 431-130-1 — Aquatic Chronic 4 H413 — H413

616-145-00-3 pethoxamide (ISO); 2-chloro- N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide — 106700-29-2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=100

616-146-00-9 N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide 431-330-7 142776-95-2 Aquatic Chronic 4 H413 — H413

616-147-00-4 1-methyl-4-(2-methyl-2 H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide 424-160-1 139481-22-4 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

616-148-00-X N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide 424-550-1 84245-12-5 Carc. 1B Muta. 1B Repr. 1B H350 H340 H360FD GHS08 Dgr H350 H340 H360FD

616-150-00-0 (2 R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride 425-260-6 — STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H373** H318 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H373** H318 H317 H411

616-151-00-6 N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide 425-650-6 171887-03-9 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412

616-152-00-1 4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3, N-diphenylbutanamide 425-850-3 125971-96-2 Aquatic Chronic 4 H413 — H413

616-153-00-7 4-methyl-3-oxo- N-phenyl-2-(phenylmethylene)pentanamide 425-860-8 125971-57-5 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

616-154-00-2 3,4-dichloro- N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide 431-110-0 — Aquatic Chronic 4 H413 — H413

616-155-00-8 N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide 431-040-0 104560-40-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

616-156-00-3 6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[ N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide 430-500-8 204277-61-2 Aquatic Chronic 4 H413 — H413

616-157-00-9 3-amino-4-hydroxy- N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride 427-780-9 114565-70-7 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410

616-158-00-4 N-[4-cyano-3-trifluoromethylphenyl]methacrylamide 427-880-2 90357-53-2 STOT RE 2 * Aquatic Chronic 2 H373** H411 GHS08 GHS09 Wng H373** H411

616-160-00-5 2,2'-azobis[ N-(2-hydroxyethyl)-2-methylpropionamide] 429-090-3 61551-69-7 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412

616-161-00-0 2,4-dichloro-5-hydroxyacetanilide 429-110-0 67669-19-6 Aquatic Chronic 3 H412 — H412

616-162-00-6 isostearic acid monoisopropanolamide 431-540-9 — Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411

616-163-00-1 4,4'-methylenebis[ N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide] 430-350-3 192463-88-0 Aquatic Chronic 4 H413 — H413

616-164-00-7 dimoxystrobin (ISO); ( E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide — 149961-52-4 Carc. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H351 H361d*** H332 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361d*** H332 H410 M=10

616-165-00-2 beflubutamid (ISO); ( RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide — 113614-08-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M=100

616-166-00-8 cyazofamid (ISO); 4-chloro-2-cyano- N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide — 120116-88-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M=10

616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide 418-290-6 168612-06-4 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317

616-168-00-9 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium 418-440-0 136997-71-2 Skin Sens. 1 H317 GHS07 Wng H317

616-169-00-4 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one 420-220-4 92771-56-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

616-170-00-X (2 R)-2-amino-2-phenylacetamide 420-370-0 6485-67-2 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317

616-171-00-5 2-(para-chlorophenyl)glycineamide 420-830-0 102333-75-5 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317

616-172-00-0 N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl 423-840-3 14691-89-5 Acute Tox. 4 * H302 GHS07 Wng H302

616-174-00-1 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride 424-560-4 151257-01-1 Acute Tox. 4 * Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319

616-175-00-7 2-(2-hexyldecyloxy)benzamide 431-230-3 202483-62-3 Aquatic Chronic 4 H413 — H413

616-176-00-2 3- N,N-bis(methoxyethyl)aminoacetanilide 432-530-7 24294-01-7 Acute Tox. 4 * Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412

616-177-00-8 (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1 H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide 432-970-1 217324-98-6 Aquatic Chronic 4 H413 — H413

616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide 434-500-9 52583-35-4 Aquatic Chronic 4 H413 — H413

616-179-00-9 2-chloro- N-(4-methylphenyl)acetamide 435-170-9 16634-82-5 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410

616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride 435-470-1 27366-72-9 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D*** H400 H410 GHS08 GHS09 Dgr H360D*** H410

616-181-00-X 4'-methyldodecane-1-sulfonanilide 435-490-9 17417-32-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

616-182-00-5 N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide 435-860-1 214417-91-1 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411

616-183-00-0 N-dodecyl-4-methoxybenzamide 442-340-6 1854-15-5 Aquatic Chronic 4 H413 — H413

616-184-00-6 3-methyl- N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide 442-560-2 105043-55-8 Aquatic Chronic 4 H413 — H413

616-186-00-7 N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) 443-010-4 53641-10-4 Aquatic Chronic 3 H412 — H412

616-188-00-8 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo- N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide 443-980-9 221215-20-9 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide 444-780-4 452962-97-9 Aquatic Chronic 4 H413 — H413

616-190-00-9 N-decyl-4-nitrobenzamide 445-880-0 64026-19-3 Aquatic Chronic 4 H413 — H413

616-191-00-4 2-ethyl- N-methyl-N-(3-methylphenyl)butanamide 446-190-2 406488-30-0 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H302 H319 H315 H317 H411 GHS07 GHS09 Wng H302 H319 H315 H317 H411

616-192-00-X 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'- tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide 448-060-0 727678-39-9 Aquatic Chronic 4 H413 — H413

616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide 449-940-7 368450-39-9 Aquatic Chronic 4 H413 — H413

616-194-00-0 2,2-diethoxy- N,N-dimethylacetamide 449-950-1 34640-92-1 Eye Irrit. 2 H319 GHS07 Wng H319

616-196-00-1 disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)- N-dodecyl-2-naphthamide 419-990-4 — Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410

616-197-00-7 reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide 422-500-1 — STOT RE 2 * H373** GHS08 Wng H373**

616-198-00-2 1,3-bis[12-hydroxy-octadecamide- N-methylene]-benzene 423-300-7 — Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

616-200-00-1 reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide); 12-hydroxy- N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide; N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide) 432-430-3 — Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413

616-201-00-7 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine 432-840-2 220926-97-6 Acute Tox. 4 * Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413

616-202-00-2 reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[ N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]- N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]- N-(2-carboxylphenyl)-3-oxo-butanamide 434-330-5 — Carc. 2 Skin Sens. 1 Aquatic Chronic 4 H351 H317 H413 GHS08 GHS07 Wng H351 H317 H413

616-203-00-8 reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide 442-280-0 — Aquatic Chronic 4 H413 — H413

616-204-00-3 N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea] 451-060-3 122886-55-9 Aquatic Chronic 4 H413 — H413

617-021-00-1 methylethylketone peroxide trimer 429-320-2 — Org.

Perox.

B**** Asp.

Tox. 1 Skin Irrit. 2 Skin Sens. 1 H241 H304 H315 H317 GHS01 GHS02 GHS08 GHS07 Dgr H241 H304 H315 H317

617-022-00-7 reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate 442-480-8 — Org.

Perox.

C Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H242 H302 H314 H317 H411 GHS02 GHS05 GHS07 GHS09 Dgr H242 H302 H314 H317 H411

647-017-00-5 laccase 420-150-4 80498-15-3 Resp.

Sens. 1 H334 GHS08 Dgr H334

Diese Seite zeigt die aktuelle Fassung (Quelle: © Europäische Union, https://eur-lex.europa.eu). Für tagesaktuelle, zitiersichere Abfragen lässt sich Anhang II REG_2009_790 und jede andere deutsche oder europäische Rechtsquelle live per Lawbster-MCP abrufen.

Kann ich Anhang II REG_2009_790 direkt in ChatGPT oder Claude abfragen?

Ja. Über Lawbster (MCP-Server) greifen KI-Assistenten wie Claude, ChatGPT, Cursor und Copilot Studio — oder eigene Anwendungen per REST-API — direkt auf den tagesaktuellen Volltext deutscher und europäischer Gesetze, Verordnungen und Gerichtsentscheidungen zu. Free-Tier verfügbar.

Diese Norm ist Teil von Lawbster — verifizierte deutsche und europäische Gesetze, Verordnungen und Gerichtsentscheidungen, live in jedem KI-Assistenten per MCP (Claude, ChatGPT, Cursor, Copilot Studio u. a.) oder über die REST-API. API-Key holen.